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This thesis intends to analyze and describe three different cases of digitization within the 
health sector. Even though all three cases discuss accommodating patients suffering a chronic 
disease, it is important to state that each respective case is different. Case One is a research 
project with the intent to integrate digital tools and cognitive behavioral therapy to better 
accommodate war veterans suffering chronic low back pain. Case Two is a review of peer-
reviewed literature focusing on instances of digitization measures of treating cardiovascular 
disease and the presentation of the findings and implications of applying this to low- and 
middle-income countries. Lastly, Case Three is an app-supported research project targeted at 
a variety of users, medical personnel, relatives of patients, and the general public that intends 
to simulate what it’s like to live with Inflammatory Bowel Syndrome through the use of a 
mobile health tool that inform patients of typical IBD situations.  Central to this thesis will 
also be discussing literature and providing information about the symbiotic relationship 
between recent developments within artificial intelligence and medical ethics, and the 
importance of these fields evolving both in unison and tension. The purpose for this will be to 
highlight why ethics may and should play a significant role in the designing process of 
artificially intelligent tools used in the health sector, as these tools may have a direct impact 
on our health and well-being and should, ideally, be designed to reflect ethical values. 
However, there is a diversity of approaches to ethics in general, and more specifically to 
medical ethics. Following this line of thought, the thesis will discuss various issues that arise 
when combining the fields of medicine, ethics and technology into one thesis, taking into 
consideration that these fields, individually and combined, are extensive and complex. 
Another central part of this thesis will be to address to some extent the historical context, e.g., 
the view on the “patient” and on chronic illness, in terms of ethics being a dynamic and 
evolving principle. We will look, among other things, at how medicine and health care in 
industrial and post-industrial societies have moved from a historical beneficence model that 
focused primarily on the act of researching and curing diseases to an autonomy model which 
gradually has emphasized the patients’ right to be involved in accommodating their disease. 
Central to this work, we will uncover four ethical principles that will act as a framework to 
evaluate the ethical implications in the three cases we have analyzed. The ethical evaluation 
towards the end of the thesis will present ethical implications and evaluate these using the 





Denne masteravhandlingen er en kvalitativ beskrivelse og etisk analyse av tre 
digitaliseringstiltak som er gjort for å følge opp pasienter som lider av kroniske sykdommer. 
Masteroppgaven gir en historisk innføring i den etiske utviklingen av forholdet mellom 
pasient og lege, med fokus på de fire etiske prinsippene; velgjørenhet (beneficene), ikke 
skade (non-maleficence), rettferdighet (justice) og respekten for selvbestemmelse 
(autonomy). Disse fire etiske prinsippene vil være rammeverket som utgjør den etiske 
analysen av de tre digitaliseringstiltakene oppgaven tar for seg. En sentral del av 
masteravhandlingen vil være å belyse at det kreves et tverrfaglig samarbeid mellom flere 
fagfelt for at teknologi og helse skal følge etiske normer. Masteravhandling diskuterer hvilke 
etiske implikasjoner vi møter når etikk og digitalisering møtes i et symbiotisk forhold 
innenfor medisinske oppfølgingsmetoder. Noen eksempler på etiske implikasjoner vil være 
generasjons gap i forbindelse med brukervennlighet av digitaliserte medisinske tiltak, 
rettferdig fordeling av medisinske tiltak og ressurser uavhengig av økonomisk og geografisk 
bakgrunn og stigmatisering av enkelte pasientgrupper som lider av kroniske sykdommer. De 
tre digitaliseringstiltakene er forskjellige i deres metodiske gjennomføring som utspiller seg i 
ulike etiske utfordringer relatert til de fire etiske prinsippene. Oppgaven belyser viktigheten i 
at gode etiske retningslinjer må gjenspeiles i utviklingen og gjennomføringen av digitaliserte 
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“A society grows great when old men plant trees in whose shade they know they 
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Imagine an inverted triangle. Going from top to bottom, it starts out broad and then gets more 
pointed towards the end. Building on that analogy, I intend, in a first phase, to approach the 
thematic issues raised in this thesis broadly, and, in a second phase focus specifically and 
with greater detail on highlighted issues and perspectives. The general approach will build 
upon insights that the digitization of health measures and the ethical implications surrounding 
these digitized measures involve many layers of the notion of “technology”, which will be 
addressed in due time in these pages. 
 
The title of this thesis “An Ethical Evaluation of Three Digitization Measures in the Health 
Sector: How to Better Accommodate Patients Suffering Chronic Diseases” suggests modestly 
how difficult it may be to fathom at once the complexity of addressing various encounters 
between healthcare and networked technologies and Artificial Intelligence. Analyzing and 
assessing such encounters requires dealing with fields of research stretching across a wide 
spectrum. For instance, because the thesis is “an ethical evaluation”, the field of 
philosophical ethics cannot be avoided fully when designing the research approach in this 
thesis. However, dealing with the complexity behind the topic of this thesis does not end 
there. One can still peel off further layers of “the onion’s skin” and propose that the thesis 
does not only concern itself with the general field of philosophy, but needs to involved the 
more specialized domain of  moral philosophy, taking into account recent development 
within its subfield of ‘ethics of health’, ‘healthcare ethics’ and ‘medical ethics’, while 
including  dimensions specific of the recent development of networked information and 
communications technology (ICT) and, e.g., social media, privacy and individual rights. 
Moreover, we can apply this same approach to other parts of the thesis title, e.g., “How to 
Better Accommodate Patients Suffering Chronic Diseases”, one understands that invoking the 
research field of medicine is crucial in the process of writing this thesis, with bioethics (not 
totally reducible to 'medical ethics') being another layer of complexity. The last part of the 
title – “three digitization measures within the health sector” adds another layer of 
complexity, namely the various dimension of applications of digital technologies in the health 
sector, e.g. mediated interaction and Artificial Intelligence. Correspondingly, one can also 
peel the metaphorical onion in this case and discover that digital is a rather general term that 
can describe hardware such as digital electronics, socio economic phenomena such as digital 
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culture and other uses like digital data, digital media, digital radio and television, and so 
forth. The list is seemingly endless. We will from there endeavor in this thesis, to focus on 
specific aspects of digitization exemplified through three cases studies. 
 
Going back to our inverted triangle analogy, the intention is to offer the reader a contextual 
understanding justifying an initial broad approach to be followed by a more detailed analysis.  
This is imitating this work by describing the contextual setting is crucial. We cannot speak of 
context without using the metaphorical “zoom button” and zooming all the way out so that 
we may see the big picture. Therefore, the intention of this next section will be to give 
thought to the idea of The Fourth Industrial Revolution, as proposed by Klaus Schwab. This 
is the ultimate big picture, as it describes everything within the title of this thesis. It is as far 
as we can “zoom out”, in order to understand what is going on in this era of where 
technology seems to be a key factor in our day-to-day life. 
 
In this section I want to take some time to write about the almost perplexing reality that has 
begun to take shape in front of us. We’re talking about the idea of the Fourth Industrial 
Revolution (4IR). This term was coined by Schwab (2016) to capture the discourse going on 
across emerging technological fields such as robotics, artificial intelligence, nanotechnology, 
quantum computing, biotechnology, the Internet of Things, the Industrial Internet of Things, 
fifth-generation wireless technology (5G), additive manufacturing/3D printing and fully 
autonomous vehicles, to name some. One can argue that a term like “The Fourth Industrial 
Revolution” allows us to “zoom out” from the ongoing discourse in all these technology-
infused fields and capture them all under one term, much like an umbrella. This conceptual 
umbrella allows us to include synergies and possible convergences between various fields of 
research, development and industry and address these using a collective term. Using such a 
collective term may challenge one to see the big picture, namely the historical context and 
realizing the changes that we’re currently going through, and ultimately leading us to 
understand better the specific implications this may have in regard to ‘digitized 
accommodation systems’ (this will, hereinafter, be used as a generic term) in the health 
sector. 
 
A closer look at the notion of 4IR will highlight contextual aspects of ‘digitized 
accommodation systems’ in the health sector. As stated above, the 4IR vision has been 
promoted by Klaus Schwab, Founder and Executive Chairman of the World Economic 
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Forum, who has been a central actor and contributor to global affairs for over four decades. 
In his book, ‘The Fourth Industrial Revolution’ (Schwab, 2016) the author exposes his theory 
that we are currently living in what is termed the Fourth Industrial Revolution, which he 
characterizes by a range of new technologies that are fusing the physical, digital and 
biological worlds, impacting all disciplines, economies and industries, and even challenging 
ideas about what it means to be human (Schwab, 2016, p. 6). More concretely, Schwab 
(2016), explains how the digital dimension is changing healthcare and ventures into outlining 
the potential this evolution has: 
 
“Many of our intractable health challenges, from heart disease to cancer, have a 
genetic component. Because of this, the ability to determine our individual genetic 
make-up in an efficient and cost-effective manner (through sequencing machines used 
in routine diagnostics) will revolutionize personalized and effective healthcare. 
Informed by a tumours genetic make-up, doctors will be able to make decisions about 
a patient’s cancer treatment” (Schwab, 2016, p. 26) 
 
Schwab’s sentiment that cost-effective and sufficient digitized treatments in health care is 
visible through the various ways that society has become deterministic in the sense that they 
not only use technology for practical reasons but thrive on technology. However, thrive is a 
strong word and should not be used unless it fits the context, but it is the word that I 
personally would use to describe our increasingly digitized culture. An example of just how 
much we “thrive” on technology would be the inherent obsession with self-surveillance 
through mobile health tools. In fact, there are as much as 48 companies investing in mobile 
health tools as of 2017, highlighted by Terry (2017) in a quite recent article about companies 
investing in the mobile health market. While this number may not be particularly high, it is 
mentioned because all these 48 different companies have different technological approaches 
to digitized health, e.g., medically oriented apps using artificial intelligence, mobile health to 
collect big data samples, image detection technology, molecular technology, AI chatbots to 
retrieve information and council patients, social media approaches for information awareness, 
reinforcement learning through adaptive processes, to mention only a few. 
 
The fact that the statistics, going back one year to 2017, show this amount of companies 
investing in a wide spectrum of digitized health accommodating systems could be argued as a 
sign of a progressively more autonomous culture. We have come so far on the spectrum of 
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investing resources into the technology and digitization that one may even entertain the idea 
of human beings being an extension of technology (and vice versa), as suggested by Lawson 
(2010), which adds a more radical and possibly disturbing scene to Schwab’s vision of the 
Fourth Industrial Revolution.  
 
Because such a fundamentally impactful movement of technological development in our 
society has led to what Schwab refers to as the Fourth Industrial Revolution, it is fair to say 
the general population might have noticed that this revolution affects so many areas that it 
ultimately challenges what it means to be human, because the combining of ethics into 
machinery raises some problematic moral and ethical issues, e.g., questions of this nature: 
What are the implications of creating algorithmic machinery that will impact us physically, 
mentally, socially on a day-to-day basis? In which aspects should pre-defined algorithmic 
code define a mechanic behavior? These are crucial challenges that humanity must face, 
according to Creighton (2016) in her contribution about “The Evolution of AI: Can Morality 
be Programmed?”. Answering such questions become difficult because, optimally, one would 
want machine behavior to reflect moral values if it is responsible for tasks such as treating 
patients, however, the variables that determine what moral values a person will follow are 
relying on too many factors. Such variables could be culture, orientation, socio-economic 
background or thousands of different factors, according to Creighton (2016). Such challenges 
are almost impossible to solve, unless there is a collaboration between different disciplinary 
areas to ensure that The Fourth Industrial Revolution will not end with a future dystopia, 
abundantly imagined in literature and films.  
 
Taking the measure of these challenges, and relating these to various initiatives aiming at 
improving the life of patients suffering from chronic diseases through various technological 
measures, one has to incorporate fields such as neuroscience, psychology, moral philosophy, 
digital culture, as well as various other disciplines, in order to establish a foundation of 
ethical truth and social dependability that may contribute to shape guidelines for establishing 
such life changing technological developments within digitized healthcare in general and 
more specifically, digitized accompanying measures for chronic illness. Hopefully it has 
become clear at this point that the cooperation and symbiotic relationship between ethics and 
engineering developments related to AI need to be better tuned, and that co-development of 
ethical and algorithmic measures is desirable in order to ensure that the underlying algorithms 
and data structures defining virtualized behaviors in AI will enforce moral values that reflect 
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what is considered ‘good’, described by Conitzer (2016) as the moral apex. 1This moral apex 
is considered the ultimate good, and is what we should strive for, but it proves to be a 
challenge because the moral apex is dynamic and what is considered ‘morally good’ today 
might change in a 100 years from now as it is now exemplified by the case of slavery being a 
less stigmatized and more acceptable practice 100 years ago, but generally considered to be 
morally reprehensible in society today (Conitzer, 2016). This a statement following the 
interview that Creighton (2016) highlights.  
 
“If we did the same ethical tests a hundred years ago, the decisions that we would get 
from people would be much more racist, sexist, and all kinds of other things that we 
wouldn’t see as ‘good’ now. Similarly, right now, maybe our moral development 
hasn’t come to its apex, and a hundred years from now people might feel that some of 
the things we do right now, like how we treat animals, is completely immoral.” 
(Conitzer, 2016) 
 
The goal for what is considered the ‘moral apex’ is therefore always shifting, and this should 
be taken into consideration when dealing with ethical aspects linked with digitized 
accompanying measures.  
 
In our culture the emergence of machinery possibly capable of human level intelligence has 
in the latest years been booming on the agenda of political parties, academic scholars, 
researchers and scientists alike, as attraction to the unknown is a common denominator in 
society. One could deem such a fascination for artificial intelligence (or what is believed to 
be such), as a strange attraction to the unavoidable dystopian nature of AI, rooted in the 
psychological trait of humans being ‘morbidly curious’ and thus wanting to explore the 
‘unknown’ at the risk of perishing. However, this is a mere hypothesis and a personal attempt 
at justifying the attraction to AI. It is also understandable that the field of artificial 
intelligence has gotten increased attention because of its already achieved and expected 
future capabilities. While this thesis will not specialize in recent ‘bleeding-edge’ 
developments of A.I, but rather will address a more general endeavor towards offering 
chronic patients ‘intelligent’ digitized accommodation, the debate about the implication of 
                                               
1 The Moral Apex (Contizer, 2016) is terminology of a moral peak that can never be reach due to 
morality being dynamic in nature and changing depending on current values reflected in society. 
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Artificial Intelligence will have bearings on follow-up systems with no or very rudimentary 
aspects of ‘machine learning’. 
 
However, it is safe to say that if our goal is to accommodate patients suffering chronic 
diseases with ethics in mind, it requires a collaboration of different academic fields coming 
together, as the emergence of advanced artificial intelligence in the health sector requires the 
collective attention of different perspectives, in order to ensure the well-being and safety of 
our people, especially when AI concerns itself with the health sector, as this has direct 
correlation to our health and well-being. If mistakes based on misinformation or lack of 
inquiry are made in the ethics department of an AI designed to accommodate a patient, one 




2.1 Looking Back: Gaining Perspective  
 
In my life I have always been drawn to the technological dimension, mostly through the use 
of computers. Reflecting upon the historic context and the causal connections leading up to 
events in my life has always been important to me, as I find that it brings clarity in how 
events have unfolded in relation to digital technologies. That is why I am going to first go 
through the events that have led to my interest in digital technologies, cultures and AI’s 
potential to achieve enter a state of symbiosis with human nature, which is in essence what 
this thesis is about; finding the ethical dilemmas of a world in which technological tools has 
become more than mere tools, but rather an extension of our image.  
 
My basic approach is that we find ourselves in our use of technological devices, as these 
reflect and expand our behavior and help us adapt to the surrounding world. Additionally, 
one could point out that technological devices, including digital technologies, have an agenda 
of their own, which indeed would constitute a specific ethical issue. However, problems are 
likely to ensue when technological apparatuses encourage or provoke patterns of behavior 
that are not considered morally sound by current standards. One can therefore say that the 
irruption of digital technologies in modelling, e.g., the behavior of chronic patients, actualizes 
more deep-rooted issues linked with what is actually considered to be morally sound and 
reprehensible in the current health care context in advanced welfare societies. A key 
challenge when dealing with ethical issues, e.g., in health care, is whether there exists 
objective guidelines, standards, norms and procedures as to what should be implemented into 
the artificial, when morality relies on the subjective nature of human thought process. These 
thoughts, most particularly the embeddability of ethical systems in digitized accompanying 
measures in healthcare, have occupied my mind for a little over five years now, and I find 




2.2 Medicine: My Affiliation with the Health Sector 
 
I would consider myself fairly familiar with the health sector and how it operates due to my 
extensive private involvement with the health sector, being someone who suffers from a 
chronic disease myself. In fact, for the past 15 years I have suffered from Crohn's disease, a 
Inflammatory Bowel Disease (IBD) that affects the bowels through irritation or inflammatory 
symptoms. Numerous doctor visits for treatment and care for my Crohn’s disease has led me 
into occasionally questioning some actual procedures and findings of physicians. However 
timid in the past years, the disease has been followed up through frequent doctor 
appointments and it led me into being intrigued by the extensive institutional, clinical and 
technical apparatus addressing the needs of chronically ill patients.  
 
Through consultations for treatment of IBD, and frequent conversations with physicians 
treating IBD, I have accumulated several experiences and reflected over how the process of 
treating and accompanying IBD works for individual patients. I have tried to apply my 
current knowledge of digital culture and my general interest in what I often refer to as 
abstract topics, e.g., critical approach to questions pertaining to ethics and morality, and 
endeavored to integrate these interests with my experience of being an IBD patient in the 
Norwegian health sector.  
 
More concretely, and of particular importance to accommodating patients suffering chronic 
disease, a hypothesis that has entered my mind when receiving consultation for my IBD has 
been that patients suffering of this disease are all quite different in terms of how aggressive 
their disease is, and that, as a consequence, the required action from physicians in 
accommodating patients suffering IBD should vary depending on each person’s symptoms - 
ultimately rendering the clinical aspects in treating IBD rather difficult to carry out. I 
consider myself lucky to not have the worst symptoms of IBD, but during consultations in 
which myself and other IBD patients are administered medicine through intravenous 
treatment during a whole hour it is not uncommon to have conversations with fellow patients 
of IBD regarding their symptoms and disease. It is noticeable then that the notion of ‘patient’ 
covers a wide spectrum of clinical and subjective situations, e.g., there are patients suffering 
far worse inflammatory symptoms than myself, leading such patients to struggle a lot, both 
mentally and physically, as a result of this. It is at this point, that more adapted, possibly 
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intensive, and hopefully cost-efficient (e.g., achieving more coverage) methods of 
approaching the problem of accommodating patients suffering from IBD enter my mind, and 
it is ultimately the reason as to why this topic was chosen. The numerous consultations, and 
the experience I have myself with IBD and accompanying measures to treat IBD in the 
Norwegian health sector, coupled with my interesting in digital culture, and a penchant 
towards reflecting over the abstract and therefore intriguing nature of morality and ethics 
– all these areas of interest and concern are reflecting in the various sections of this thesis. 
  
2.3 Ethics: Questioning the Origin of Morality 
 
Linking knowledge of the past with prospects for the future appear to me to be more thought-
provoking than merely describing the present state of things, which is where the philosophy 
of ethics comes into question. Ethics is not a static discipline but is dynamic in every sense of 
the word, as it relates to a rich variety of situations and applications and contexts, and in its 
contemporary academic form incorporates key insights about socio-economic change, 
psychology and anthropology. In a historical perspective, the religious roots of ethics still 
may surface when discussing ethics, as there are different perspectives on where morality 
originates from, e.g. in the debate between theological or principled ethics vs. situational 
ethics. E.g., one may discuss, whether altruism may be viewed as a trait originating in a 
religious universe, or, by contrast, as an evolutionary trait, or more basically as a brain 
function that can be explained cognitively using objective arguments. These are thoughts that 
have prompted me to address the issue of morality and combine it with my affiliation and 
interest in the assumed growing potential of and reference to artificial intelligence 
(hereinafter: AI) in the health sector.  
 
One may refer to a person's stance on issues of morality by addressing their ‘moral compass’, 
which will vary depending on the person, his/her culture, surroundings, upbringing and 
virtually every single occurrence that has happened in the person's life. There are so many 
factors that will determine an individual's moral compass. Such insight leads us to assume 
that notions about morality indeed are quite abstract, contextual, and adaptable, and the 
possible gaps between acceptable behaviors and abstract norms are numerous and varied. The 
subjectivity of moral appreciations, decisions and evaluations needs to be dealt with in 
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practical situations, as well as in academic ethics. This fruitful tension between context, 
situation and abstract norms is the reason that I am attracted to the ethics of healthcare and 
have incorporated this dimension in the scope of my thesis. Followingly, I will discuss such 
ethical issues one can find in the digitized accompanying measures that are developed and 
proposed to accommodate patients suffering chronic diseases. Such findings will be outlined 
in the chapter for ‘Understanding the Historical Perspective’, which discusses Gillon’s (1994) 
four principles which, according to the author, can constitute a framework for medical ethics 
in the health sector. 
 
2.4 Technology: an extension of humanity or vice versa? 
 
Thirdly, the next piece of the puzzle added to my analysis will be motivated by my interest in 
the consequences of digital technologies and digital culture. Such interest traces back to the 
fact that I find anything that is considered abstract, open, and ‘unsolved’ to be of interest, 
e.g., digital culture spans across vast research fields while involving us on a daily basis. A 
basic underpinning for this thesis is that most individuals around the world are, knowingly or 
unknowingly, surrounded by and using, directly or indirectly, digital technologies and 
incorporating elements of digital culture individually or collectively, be it voluntarily by 
participating in social media websites like Facebook, Instagram, Twitter, Snapchat and the 
likes, or unwillingly by appearing on surveillance cameras all over the world. We all partake 
in digital culture and it is a vast, extensive field. I do not only associate strongly with digital 
culture because it is my field of study and research, but also because I am an avid user of the 
computer and the Internet. I have adopted the culture that has emerged around digital 
technologies, I have become, to use simplified characteristics, a technological determinist 
who believes technology shapes us. However, I find it crucial to examine critically the use of 
digital technologies and explore ethical implications of digitized measures in the health 
sector. Technology has always been an extension of humanity, but I fear that, without 
intervention and careful examination, humanity might become an extension of technology. It 
might not be evident right now, but even more terrifying are the small changes and seemingly 
unnoticeable changes, because these are changes that fly under the radar. Much like looking 
at yourself in the mirror every day and not noticing that you’re gaining weight because it 





This chapter intends to outline the methods used in this thesis to acquire and combine 
information and explain in which aspects the information inquiry process could be defined as 
a multi-method qualitative research process. Additionally, this section will assess the 
credibility and possible disadvantages of the primary source material referenced in this thesis, 
e.g., determining if there are benefits or disadvantages in using each respective source. 
Another part of this section will consist of a presentation of the four ethical principles in 
medicine (Gillon, 1994) which will be the framework for ethical evaluation of the three cases 
in this thesis.  
3.1 Qualitative Research 
 
The method describing the information inquiry in this thesis is reflective of the basic 
philosophy of qualitative research, e.g., emphasizing contextual aspects, multi-perspective 
approaches, and ethical concerns. I have gathered case material from various sources using 
widely used search engines, such as Google Scholar, ensuring that I may collect potentially 
reliable peer-reviewed contributions, e.g., in scholarly journals and academic theses. In this 
thesis the premise involves an ethical evaluation and requires discussing and individual 
reflection, adding a fully assumed reflective dimension to the enquiry process, and is 
different from quantitative research focusing on detached and objectivizing statistical 
analysis. Consequently, the approach followed in this thesis more argumentative, e.g., 
regarding the ethical implications of the studied cases. This approach is in line with the 
general approach within academic moral philosophy, which is a dynamic and less ‘clinical’ 
domain of knowledge, emphasizing various contextual aspects and dilemmas.  
3.2 Information Inquiry 
 
In this section I will explain how I acquired information leading to my findings, ranging from 
the mixed use of search engines to interviews and collaborations. The main purpose of this 
section is to allow the reader to formulate an opinion on how the information that was 
acquired and systematized is relevant.  
 
 21 
3.2.1 Use of search engines 
 
Most of the resources acquired in the research of relevant literature was through Google 
Scholar, allowing me to find reliable and, where possible, peer-reviewed articles, journals 
and doctoral theses. Previous knowledge of the reliability and credibility of Google Scholar 
led me to do most of my inquiry in terms of gathering credible and relevant resources in 
Google Scholar, as the scope of the thesis is based on modern research, rather than research 
dating back to research that are only available on paper. To expand on this point, Google 
Scholar was launched in 2004 and covers most journals and academic articles published 
online, making it an ideal candidate in the methodological approach of information inquiry of 
this thesis. Using Google Scholar, I was able to find newfound knowledge and up-to-date 
information to support my thesis. I was assisted by my thesis supervisor as well in finding 
and discussing relevant resources that could potentially be of use. When reviewing resources 
related to the scope of my thesis, I concentrated on contributions which addressed the fields 
of healthcare ethics, medicine (chronic illness) and digital technologies. A key challenge was 
to find freely accessible articles, as most relevant peer-reviewed articles were published in 
journals that require a commercial subscription or purchase of the article. I ended end up 
purchasing several articles related to the topic, as free articles were seemingly scarce.  
 
3.2.2 Interviews and collaborations 
 
I initiated my project, in the pilot phase, conducting an informal interview with Hilde Løland 
Volkmann, PhD/MD at Haukeland University Hospital, specialist in chronic disease, to 
address the potential challenges posed by a research project which ambition to implement an 
AI based artificial agent to accommodate patients suffering from chronic diseases.  
 
The purpose behind this inquiry was going to be to gather contextual knowledge of the 
potential behind this research project, but also gather useful knowledge that could potentially 
lead me to other references or be a direct source within my thesis. Following this meeting, I 
got positive confirmation that the research project was interesting being that it affected 
Volkmann’s field of research directly. It also served as motivation because an outside party 
could confirm in person that the research project scope was, quote, “an interesting field that 
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could definitely benefit from ethical analysis” (Volkmann, 2018). Though it did not serve as 
a direct source of reference in my work, e.g., through transcripts of the discussions, I was 
grateful to have the opportunity to meet Volkmann and be able to share some of my findings 
with her, as it ultimately prompted motivation and insightfulness from my perspective.  
 
Another line of inquiry related to providing information on the historical context of how 
medical ethics have evolved from the Hippocratic era to a more autonomous model for 
patients in the health sector was provided by PhD fellow Henning Åge Skarbø, UiB. In an 
email exchange I was given a two-part article published in the CHEST Journal, namely “A 
Brief Historical and Theoretical Perspective on Patient Autonomy and Medical Decision 
Making - Part I: The Beneficence Model” (Will, 2011) and the following article “A Brief 
Historical and Theoretical Perspective on Patient Autonomy and Medical Decision Making - 
Part II: The Autonomy Model” (Will, 2011). Skarbø is conducting at Helse Vest and at the 
University of Bergen to develop a chatbot with the purpose of following up patients suffering 
from chronic disease. I met Skarbø through my supervisor, and I am grateful that I had the 
opportunity to share insights and discuss the thesis with Skarbø. I am also grateful that 
Skarbø led me to the CHEST Journal referenced in my thesis related to the historical context 
of ethics in the medical field, as this became a central part of my thesis. In the above-
mentioned CHEST Journal (Will, 2011), I was able to identify the historical context as to 
how the patient-physician relationship has evolved over the years, dating back to the 
Hippocratic tradition. The CHEST Journal (Will, 2011) appointed to me by Skarbø 
interestingly had the consensus pointing towards an incremental introduction of ethical 
principles in the health sector, which highlights the importance of medical ethics and 
technology evolving in a symbiotic relationship.  
 
3.3 Evaluation of the Credibility of Sources: Strengths and Weaknesses 
 
In determining the reliability and usefulness of my sources, I find it important to state that the 
use of a reliable search engine (Google Scholar) that provides peer reviewed articles, journals 
and thesis has been a deciding factor in making my thesis strong in terms of its credibility. I 
draw this conclusion based on recommendations I have gathered, e.g., in conversations with 
my peers and professors in Digital Culture, about the credibility and reliability of Google 
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Scholar. Case One and Case Two in this thesis are both published in medical journals and 
peer-reviewed. Case One exhibits a high degree of credibility (but may be nonetheless 
subject to criticism) as it been published in on PubMed Central, which is a widely cited 
archive for biomedical and life science.2 
 
As the results from Case One are expected to be available at the end of 2019, the above-
mentioned research article has been uploaded to an archive at PubMed named JMIR 
Protocols, which deals with ongoing trials, grant proposals, methods and early results. 
Another strength to this source has is that it is peer-reviewed by two independent experts on 
the scope of the topic in Case One. 
 
 
A possible critique against using this case might however be that the results of the case will 
not be ready before end of 2019, as patient enrolment began in 2016. However, Case One 
currently is being reviewed by a monitoring editor (Gunther Eysenbach). Additionally, Case 
One appears strong even though the applied research is not focusing on the ethical 
implications of accommodating chronic diseases through digitized measures in general, but 
more soberly, on the actual accompanying measures, e.g. procedures, and their observable 
effect on patients undergoing the trials. While the already observed and expected results 
themselves will indeed benefit the researchers of Case One in terms of creating similar 
functioning digital procedures to accommodate patients suffering diseases, the discussion in 
the ethical evaluation section of this thesis will deal more with the findings during the trials 
and procedural work. 
 
Case Two shares many of the strengths of Case Two, being described in a publication that is 
peer-reviewed by multiple individuals. A benefit associated by Case Two resides in the fact 
that this research article also is authored by John D. Piette (same as Case One), which means 
the approaches chosen in Case One and Case Two, may be more easily compared. Case One 
focuses on the description of an actual medical procedure using technological devices such as 
                                               
2 “PubMed Central® (PMC) is a free full-text archive of biomedical and life sciences 
journal literature at the U.S. National Institutes of Health's National Library of 




mobile health tools, pedometers to track patients and reinforcement learning to adapt to 
patient needs, while Case Two is essentially a review of peer-reviewed contributions and 
grey literature that adopts the same premise as Case One. This is an interesting dynamic, as 
one may explore ethical implications in each of the cases, regardless of one being an actual 
procedure and the other case being a review of literature. Exploiting this distinction is 
potentially productive, because Case Two reviews not just one specific case of 
accommodating patients suffering chronic disease through digitized measures, but multiple 
instances of this, which makes it an ideal candidate to draw ethical implications from, and 
even information helpful determine the results of Case One.  
 
Case Three (Takeda), regardless of it being the case with the least amount of currently 
available information, is relevant in that it offers an original and creative attempt, using a 
dedicated mobile app, to learn more about how to better accommodate patients suffering 
from Inflammatory Bowel Syndrome (IBD) including the use of additional technological 
apparatuses such as a device around the hips of the app users to track movement, and 
communicating through direct smart phone messages. I did not select this source because it 
was the most readily applicable, but because I was more impressed by such an original 
attempt at learning more about a disease, as originality can be effective contra the rather 
common methods and procedures one can find in other cases attempting to better 
accommodate patients suffering chronic diseases. One weakness however will be the fact that 
Case Three has not been published in an article yet and is not a peer-reviewed source as Case 
One and Case Two is. Attempts at contacting Takeda for more details regarding their findings 
in the research project and perhaps even getting access to the technology used to simulate 
what it's like to live with IBD was made, but unfortunately this did not result in any 
additional data or further resources to benefit this thesis.  
 
3.4 Framework for Ethical Evaluation 
 
The approach chosen to address the ethical implications in each respective case in the 
Evaluation Section will exploit the framework for ethical principles in medicine proposed by 
Gillon (1994). Gillon’s framework addresses, in my opinion, the most central ethical 
demands which digitized accompanying measures may be expected to fulfill if they are to be 
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made public or may be authorized as legal medical procedures in Western countries. In short, 
Gillon (1994) states that the four ethical principles are beneficence and nonmaleficence, 
autonomy and justice. A thorough description of these principles will be given in chapter 5 of 
this thesis, hopefully leading to inscribe the evolution of these ethical principles in a more 
fluent approach. That said, the most important part of conveying this information is to state 
that the framework for ethical evaluation will be Gillon’s (1994) four ethical principles of 
medicine as he describes them in his work.  
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4 Cross-disciplinary Contributions to the Ethics of A.I 
 
In this section the intent will be to shed light on the complexity and difficult nature of 
researching ethics, medicine and technology, being that these are fields that requires a tightly 
knit symbiotic relationship between the different research fields. It is important to highlight 
this complexity because it paves way for some of the ethical implications to enter the domain 
of this thesis, as we shall see in the following section.  
 
4.1 Perspectives from Cognitive Sciences 
 
Through research and development in the cognitive sciences, such as neuroscience and 
psychology, we have gained more insights into how the conscious and subconscious brain 
functions, as proposed by Glaser et. al (2017). Such understanding constitutes a crucial step if 
we are to reproduce aspects of the human brain, (e.g. cognition or elementary consciousness) 
within a ‘computerized brain’ build upon advanced AI algorithm. While ambitious, and even 
utopian versions of AI, e.g., mind algorithm consciousness, may belong to science fiction, 
there are more pragmatic approaches to AI, e.g., Machine Learning (essentially algorithmic 
pattern learning classification and feature identification) which may be implementable in a 
real-life situation and offer short-term benefits. E.g., tasks in the health sector that are meant 
to improve, e.g., self-management of chronic patients are frequently of a repetitive nature and 
call for recurrent actions, such as giving medicine or mapping and following up a patient’s 
mental state. Piette (2016) proves that machine learning processes like reinforcement learning 
is a sufficient alternative. Processes involved in a typical chronic patient follow-up are 
amenable to be supported and enhanced by current AI techniques. (Glaser et. al., 2017). AI, 
even in its current state of development, may offer significant improvements in chronic 
patient care as it offers opportunities to remove cognitive biases and erroneous behavior that 
human beings display in their work in the medical field. AI is purely technical – algorithmic 
– and does not require the same neurological symbiosis as the human brain does. For 
instance, suffering from a chronic mental illness or simple cognitive bias can be ruled out in 
AI created to solve certain tasks, as AI algorithms may acquire and exploit reliable 
knowledge about predictable behavior patterns which can be embedded in applied AI 
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systems. In medical care situations, AI’s capability to adapt to certain given parameters and 
variables has, as displayed in all cases of this thesis, predictable and measurable results.  
 
4.2 Philosophical Considerations 
 
Optimally, the yet-to-come advanced AI would have to be assigned some kind of personhood 
and follow a set of moral codes reflecting ethical guidelines and social norms that are widely 
accepted in contemporary society today. Because, if we are to allow advanced AI to live side 
by side with us, we must ensure that AI systems are capable of taking moral decisions, 
something that ultimately would require advanced AI to incorporate some aspects of human 
subjectivity. This is a challenge as being subjective and able to make judgement calls 
involves being aware of the decisional context, the situations and having some “moral 
compass. As of writing, an algorithmic moral ‘subject’ is still a not currently achievable 
through code & algorithmic behavior, but aspects of ethical analysis complying with ethical 
standards may be integrated in decision-making systems. Consequently, the emergence of 
advanced AI calls for integrating central themes of moral philosophy. To do so, it is 
necessary to acquire an understanding of various approaches to the philosophical notion of 
morality. Such considerations may constitute a crucial and unavoidable step when attempting 
to model and implement ethical analysis as a core function of an AI-based support system to 
accommodate patients in the health sector. In doing so, we may re-actualize ancient questions 
already covered extensively by moral philosophers. The main problem is related to the 
argument that moral persons are subjective by nature and we cannot truly determine what 
should be a universally, objectively correct set of ethical guidelines that represent humanity 
as a whole. AI systems need therefore to clarify which ethical fundamentals are adopted. 
4.3 Economical Aspects 
 
Another academic field of research, which calls for ethical reasoning is the field of 
economics. One of the most predicted and perhaps most debated implications of advanced AI 
is the increasingly autonomous behavior of AI, which makes them e.g., optimal job 
candidates, as they potentially could replace human beings in the job market, and especially 
in key activities within health sector as human errors have a critically damaging effect, 
 
 28 
ultimately rendering humans jobless. Hisieh (2017) addresses this concern in his Forbes 
article by describing the situation from a position of someone who covers health and 
economics from a free-market perspective. 
 
“In particular, new “deep learning” artificial intelligence (AI) algorithms are 
showing promise in performing medical work which until recently was thought only 
capable of being done by human physicians.” (Hisieh, 2017) 
 
This notion again highlights what is central to this thesis, that AI in the health sector (but also 
virtually every other sector that uses AI) must be in unison human values. The AI must 
correspond with what a society wish to achieve, which becomes a challenge when faced with 
the fact that different people want different outcomes, depending on variables that affect said 
person's life. In respect to the ethical discussion of this thesis, one can entertain the question, 
“Is it truly ethical to invent AI with the capability to replace human agents in their line of 
work if the implication of creating such advanced AI is that we might suffer from its 
emergence into the job market?”. Being a radiologist, Hisieh (2017) would argue that one 
should not worry about the future of the job market as new jobs will be created at the same 
rate that they disappear, which is a general belief that society also shares in discourse 
surrounding autonomous behavior. Hisieh, even though he is a radiologist, is more of an 
optimist as he argues the following: 
 
“In time, AIs will likely displace many practitioners in many branches of medicine, 
including my own specialty of radiology. But for all of us, the potential benefits 
outweigh the short-term costs. I, for one, welcome our future AI medical experts.” 
(Hisieh, 2017) 
 
To what extent do we have the right to invent AI and establish a power-relationship in which 
we are the “owner” of this AI, and do we have the right to predetermine the destiny that this 
AI would seek out? One could draw parallels to a most unjust, unrighteous and unethical time 
in history, for instance when it was legal to own slaves. To solve this ethical dilemma, one 
would have to assess the ethical dilemma of implementing personhood in advanced AI, 
which is a determining factor in terms of their right to ethical guidelines. Nevertheless, our 
sustainable future in the health sector rests upon a sufficient understanding of AI, as 
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advanced AI would undoubtedly be a fundamental change to the health sector that can 
revolutionize the way in which patients receive treatment.  
4.4 Generational Implications of Adapting AI to Digitized Health 
Methods 
 
The next ethical question and field of research challenged by the implementation of AI in the 
health sector is related to generational aspects. This field of research involves generational 
studies and is generally concerned with the challenge to adapt AI to different age groups in 
the medical field. One challenge for developers in AI-based patient care systems is: how can 
one accommodate patients suffering chronic diseases when their perception of and abilities to 
interact with, e.g. with mobile technologies are widely different? The proposed theory is that  
 
 
Knowing this, it is important to realize that one cannot truly know the outcome of the future, 
but rather build on the foundation of valuable and credible information that scholars, 
researchers, professors and scientists have uncovered regarding advanced AI. That said, I will 
refrain from making assumptions with no basis in sufficient evidence, as one could argue that 
the emergence of advanced AI has in fact moved from the domain of fantasy and fiction to 
the domain of highly plausible, or seemingly possible theories. Though appearing as 
practical, self-explanatory information, the need to confirm the credibility and academic 
guidelines of this thesis is prevalent because the thesis will be addressing something of the 
future, namely advanced AI, and the future is not written in stone. What we know today 
might change, be altered or simply not be correct, in regard to AI, as it concerns itself with 
multiple fields and is constantly in a dynamic state in terms of its establishment in the world.  
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5 The Historical Perspective: The Evolution of Medical 
Ethics 
 
Before engaging in the in-depth discussion of the ethical implications regarding our three 
cases of digitized medical accommodation for patients suffering chronic diseases, it is 
important to be equipped with the correct knowledge and perspective of past and current 
endeavors in medical ethics, patient autonomy and medical decision making as these are 
dynamic fields that has changed dramatically over time, and is now still in its adaptation 
stage. In addressing the historical aspect of medical decision making and going from a 
beneficence model to a more autonomous model in the health sector, we will refer to Will 
(2011). We will then dive deeper into this in the following section of this thesis, discussing 
the beneficence model, the autonomy model and the four principles of medical ethics as 
described by Gillon (1994). 
 
5.1 Patient Beneficence and Medical Decision Making: The Beneficence 
Model 
 
In this section I would like to address Will (2011, 669-673), as this gives a brief overview in 
the Beneficence model and how medical decision making has been affected by a change in 
the ethical landscape over the course of 2400 years. This will be to contextualize the moral 
stance on patient-physician relations from the perspective of the Hippocratic tradition era to 
how patient-physician relations are handled in today’s society, which marks an autonomous 
shift in patient-centric relations. In the background section of this thesis I claimed that 
understanding perspective was important, as this gives you meaningful context, acting as a 
precursor to guide humanity through the challenges that was presented by artificial 
intelligence not evolving in unison with other research fields, specifically the field of ethics. 
Following that line of thinking, context is the main reason I choose to include this section as 
well, so that we understand the vastly different landscape of the Hippocratic tradition era, 




We will first start by addressing the beneficence model, which was the dominant patient-
physician model that ruled for over 2400 years (Will, 2011, 669-673). To understand why 
ethics play an important role in today’s medical ethics, it is probably convenient to go 
through the history of ethics from a medical perspective. Patients suffering chronic disease 
and other illness in the long era of Hippocratic tradition until the end 19th century were not 
assigned a meaningful role in the medical (clinical or post-clinical) decision-making process. 
This was largely because the moral landscape in the Hippocratic tradition was reflective of 
the culture and values that was prominent at the time, evident by the fact that one could own 
slaves and that was morally acceptable (in contrast to the moral stance on this today), which 
is also confirmed by Conitzer (2016) in the article referenced earlier in the thesis. This is 
exactly why morality is a dynamic principle, forever changing and evolving into a more 
developed system of showing affection and being just towards other people, treating them as 
equals. 
 
In fact, the era marked as the ‘Hippocratic tradition’ was characterized by deliberate 
withholding of information from patients regarding their chronic conditions. Physicians did 
not feel it necessary to include patients in the decision-making process, because they 
considered patients to be unaware of what was going on with them. This line of thinking, 
from today’s perspective, is considered misinformed and objectionable in many aspects. 
Being treated like e.g., a clinical ‘object’ or ‘case’ with no or minimal interest in the patient’s 
subjective experience and knowledge of his/her illness, is increasingly less accepted in 
today’s health sector, as we move from what is known as the Beneficence Model to a more 
autonomous worldview in which patients and physicians are equals. (Will, 2011, 669-673) 
 
The beneficence model did not end before thinkers like Gillon (1994) started studying the 
seemingly unfair conditions in the medical field. In fact, we can thank the philosophers of 
ethics in the Hippocratic tradition era for being able to identify the inherent value in 
respecting patient self-determination, which has been a gradual shift, but enhanced by 
addressing the lack of a framework that include ethical principles one should follow in order 
to accommodate patients in a manner that is ethical, something Gillon (1994) speaks 
passionately about in his work. Patients were eventually allowed to be part of their prognosis 
and eventually information would flow more fluently from patient to physician (Will, 2011, 
667-673). This moral evolution and culture change in the medical field that Will refers to in 
the Journal of Medical Ethics was the start of the beneficence model’s opposition, namely the 
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autonomy model; the inclusion of ethics in the medical field and ultimately the inclusion of a 
patient's legal and moral right to be an individual, rather than being treated as a research 
object, and ultimately to be informed what is going on with their health.  
 
In fact, looking back at the beneficence model, one could establish that it took 2400 years 
before anything changed (Will, 2011, 667-673). It was only because of moral philosophy and 
progressive change towards ethical values that anything ever changed, but interestingly the 
most dramatic change of all in creating a more patient-centric worldview has occurred in the 
last 100 years.  
 
Patients were allowed with the autonomy model to give their legally informed consent 
including their right to refuse the recommended treatment. Such evolution could particularly 
be observed by the way treatment was given to patients who were about to pass of old age, as 
patients then exercise a high degree of self-determination, a right that is philosophically 
valued and legally recognized in the autonomy model.  
 
Recognizing this change, one also acknowledges that the change is still going on today. In 
inventing technological devices that focuses specifically on the patient’s well-being, such as 
mobile health tools in the form of health trackers, we see that the autonomy model is 
continued even further. We are going towards an even more autonomous lifestyle in which 
patients have responsibility, control and ultimately a more patient-centric life. 
 
5.2 Patient Autonomy and Medical Decision Making: The Autonomy 
Model 
 
In the last 100 years, the autonomy model continued to be evolved (Will, 2016, 1491-1497) 
and was eventually given even more credit in law. There are now laws against doing 
unlawful practices on patients, and most importantly, the patients must consent to physicians 




These laws are available for anyone to affirm today, by visiting University Health’s website 
that list numerous laws informing patients what they can do and not do, according to the law 
in most western countries (University Health).  
 
In part two of the article published by Will (2016), it is evident that bioethics were changed 
drastically to fit a more changing world in which patients suffered various diseases that 
should not be kept confidential from the patient by the physician. Informed consent was one 
of the key parameters for confidentiality to slowly fade, and autonomy beings to evolve into 
being the morally superior practice in the health sector, as Will states,  
 
“The shift from the beneficence model to the autonomy model is governed legally by 
the informed consent doctrine, which emphasizes disclosure to patients of information 
sufficient to permit them to make intelligent choices regarding treatment alternatives. 
As this legal doctrine became established, philosophers identified an inherent value in 
respecting patients as autonomous agents, even where patient choice seems to conflict 
with the physician’s duty to act in the patient’s best interests.” (Will, 2016, 669-670). 
 
We are given new laws to live by, and ethics now play a vastly different role in medicine than 
what it previously did.  
 
5.3 Historic Perspective of Medical Ethics: The Four Principles of 
Medical Ethics 
 
In studying Will (2016), one starts to question what the actual principles of medical ethics 
are as of the 21th century. What governs physicians to conduct lawfully moral experiments 
on patients, and how does one regulate the field of medicine? Gillon (1994) refers to this 
problematic question by suggesting that there are principles that govern ethical values in the 
field of medicine, and we will discuss and take use of these principles in this thesis. 
 
“Medical ethics: four principles plus scope” found that there were four principles of ethical 
evaluation that one must consider in medical studies. Gillon (1994) addresses these four 
ethical principles when doing my evaluation of the digitization process & follow-up process 
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of chronic disease management. In short, the article and numerous other sources, state that 
the four ethical principles are beneficence and nonmaleficence, autonomy and justice. I 
intend to describe these four principles in the following sections below and use them as a 
framework in the section that attempts to evaluate the ethical implications of Case One, Case 
Two and Case Three. That is why it is crucial to understand exactly what the four ethical 
principles of medical ethics are, according to Gillon (1994).  
 
5.3.1 Beneficence and Nonmaleficence 
 
Beneficence is an ethical principle that is focused towards producing a net-benefit in medical 
situations, meaning that the outcome of a medical procedure, experiment or trial must 
produce beneficial information or an improved health state for the patient. Thus, beneficence 
describes the ‘good’ that comes from medical work. Non-maleficence is not similar in 
orientation to beneficence (Gillon, 1994, 185), but still closely tied to beneficence as it 
describes the ethical principle of not harming the patient during medical procedures, trials 
and experiments. Therefore, in a ‘good moral setting’ the overall goal of medical workers 
will always be to produce net-benefit while at the same time not harming the patient. There is 
an important distinction, however, between what the ethical principle of beneficence meant 
and what it means in today’s medical context. As we learned previously by discussing Will 
(2016), the Hippocratic tradition involved the ethical principle of beneficence. The distinction 
between what beneficence meant in the Hippocratic era compared to what it means today 
would be that beneficence in the Hippocratic era was a goal regardless of non-maleficence. 
This meant withholding information from patients, excluding them from key decisions in 
their accommodation process or physically hurting patients, because these morally 
reprehensible approaches were believed to be the most effective way of inquiring 
information. However, in more recent times, the indulgence of patient consent, background 
checks in terms of previous medical conditions and medicaments, non-harmful medical 
approaches and similar beneficial values all require careful consideration. Gillion argues this 






“Whenever we try to help others we inevitably risk harming them; health care 
workers, who are committed to helping others, must therefore consider the principles 
of beneficence and non-maleficence together and aim at producing net benefit over 
harm.” (Gillion, 1994, 185) 
 
Consequentially, from the gradual increase of non-maleficence and concern for patient’s 
wellbeing and health, we see the symbiotic relationship between beneficence and non-
maleficence coming together in digitized medical procedures. However, it can be argued that 
when the medical procedures are digitized, the ways of producing net benefit and at the same 
time not harming the patient are different than when the medical procedures are physical. 
This is a point of discussion that we will look at later in this section when using the four 




The autonomy model is important and closely related to ethics because it talks about the 
patient's right to choose, be involved and responsibility. If we have this ethical principle, we 
can make our own decisions based on deliberation. In Kantian terms, Gillon (1994, 186) 
describes this as treating patients as an end and never merely means. The autonomy model, 
especially related to digitized health, also emphasizes the patients right to self-rule and be in 
control of their own health, which is what this thesis argues. Through various digitized health 
services and procedures, we find that patients are more in control of their own health, which 
one can argue changes the way Gillon (1994) traditionally looked at autonomy in 1994 when 
the article “Medical ethics: four ethical principles plus attention to scope” was written. In 
1994 the digital health market was not as prevalent as it is now, which meant that autonomy 
meant physicians respecting a patient’s right to choose, be involved and make their own 
decisions. However, when the responsibility and notion of autonomous self-rule is shifted 
more towards the patient, e.g., a patient could use health-related apps to monitor their own 
health, the ethical principle of autonomy applies more to ‘self-rule’ than ‘respecting a 
patient’s right to make their own decisions’. A patient’s right to make their own decisions is 
already implied when digitized health tools is in the hands of patients, as they literally rule 




A patient's right to choose was not taken for granted 100 years ago, when it could be argued 
that patients were mere experimental objects in the hands of an immoral physician. However, 
with time and moral philosophy this has changed drastically. One could argue this because 
the inclusion of non-maleficence as an ethical principle and moral right gradually became 
more important as philosophers of ethics published and argued for the individual’s right to be 
informed. To be involved and being responsible is something that has also evolved heavily 
from the medical field becoming more autonomous. Patients now reserve the right to be 
involved in medical decisions that affects health, regardless of their social, economic or racial 
background. Gillon (1994, 185) consequentially describes the ethical principle of autonomy 
as a right to self-rule and self-management.  
 
The level of autonomy can be argued to be increased when medical procedures are digitized, 
furthering the level of self-management (autonomy) in the use of medically inspired 
technological devices, apps, tools and equipment. An example of this would be mHealth tools 
on your own personal mobile phone, for instance an app to measure your blood sugar. This is 
where autonomy takes responsibility into the equation, as a truly patient-centric model of the 
autonomy model comes forth through the patient actually being responsible for their own 
health. Patients can effectively monitor their own health through various mHealth tools and 




Gillon (1994, 185) also talks about the essentiality of justice. This principle is one of the most 
important in the four principles of medical ethics. In medicine, one shall experience justice as 
one does in the everyday life. Discrimination based on religion, color or other factors should 
not occur in the eyes of the law and in medical experiments, as we are all of equal value. 
Justice is therefore tied closely with autonomy, as it recognized the lawful right of citizens to 
be treated equally by physicians. Fair treatment shall be given, according to Gillon (1994, 
185). 
 
Gillon (1994) is quite specific and seemingly profound in the way he states his view on 




 “Justice is often regarded as being synonymous with fairness and can be summarised 
as the moral obligation to act on the basis of fair adjudication between competing 
claims. In health care ethics I have found it useful to subdivide obligations of justice 
into three categories: fair distribution of scarce resources (distributive justice), 
respect for people's rights (rights-based justice) and respect for morally acceptable 
laws (legal justice).” (Gillon 1994, 185). 
 
The ethical principle of justice is divided into three sub-categories, according to 
Gillon (1994, 185). Since these sub-categories of justice will incapsulate many of the 
ethical implications in the three digitization measures (cases), we are going to spend 
some time contextualizing the sub-categories of justice to understand how they might 
function and operate in practice. Fairness distribution of scarce resources (distributive 
justice) can be explained as an ethical principle that governs people’s right to receive 
treatment and receive medical equipment to self-accommodate their chronic 
conditions. It is important to note that distributive justice must also occur independent 
of socio-economic backgrounds and geographical backgrounds, to avoid unfair 
treatment based on economic, social and racial motives. For instance, if person A 
works a higher paying job than person B, they should not receive any medical benefits 
sole based on that statistic alone. Rights-based justice is also described by Gillon 
(1994, 185), but the description in the article by Gillon is rather short, which is why 
we intend to spend some time contextualizing the issue of rights-based justice. In this 
ethical principle the importance of respecting an individual’s right to deny treatment, 
opt out of medical trials and freedom to voice their opinion related to their condition 
are all determining factors when considering rights-based justice. In medical trials, 
experiments and procedures, much like the three cases mentioned in this thesis, the 
method for gaining patient consent is also crucial when it comes to rights-based 
justice. Legal justice is also brought up by Gillon (1994, 185) as an important sub-
category of justice. This ethical principle implies that one should not force a patient to 
break certain moral, social or legal laws when conducting in a medical experiment, 
procedure or trial.   
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6 Digital Platforms Targeting Patients with Chronic 
Disease: Three Cases 
 
The intended aim of this thesis will be to analyze three measures of digitization in the health 
sector and evaluate these from an ethical perspective. Synonymous to all these three 
measures is that they have been taken in order to better accommodate patients suffering 
various chronic diseases and that they are all digitized accompanying measures. The 
objective then will be to address and discuss potentially problematic or productive ethical 
challenges emanating from the three respective digitized measures to better accommodate 
patients suffering chronic diseases.   
 
I will first give a brief introduction to each of the three selected cases. The purpose of this 
exercise will be to offer the reader contextual knowledge pertaining to each of the three 
selected digitized measures, so that we may discuss the ethical dilemmas facing each case of 
digitization in the health sector later in the Chapter “Ethical Evaluation of the Cases 
Introduced: Finding the Ethical Implications in Each Respective Caseation”.  
 
6.1 Case One: “Patient-Centered Pain Care Using Artificial Intelligence 
and Mobile Health Tools: Protocol for a Randomized Study Funded 
by the US Department of Veterans Affairs Health Services Research 
and Development Program” 
 
Case One is initiated by the U.S.  The Department of Veteran Affairs (DVA). The mandate of 
this U.S. government body is to care for war veterans through appropriate health measures, 
promotion of a social environment prone to rehabilitation, and organization of support 
groups. One of the health measures promoted by DVA are digitized health accommodating 
measures, which involve the development and testing of technological tools such as mobile 
health tools and, in several cases, solutions propose involve implementing aspects of artificial 
intelligence, more specifically described as “reinforcement learning” (RL). These support 
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programs are funded by the U.S. Department of Veteran Affairs Health Services Research 
and Development Program.  
 
For the sake of simplicity, I will refer to DVA’s research project of accommodating war 
veterans using artificial intelligence and mobile health tools as Case One throughout this 
thesis, as the title of this research project is quite lengthy.  
 
In outlining the details of Case One I will attempt to give the reader context as to what 
specifically the case is about and what it intends to achieve. By doing this the reader will 
more easily understand why some aspects of the case may seem problematic, judging from an 
ethical standpoint on digitized health care systems, which is essentially what the thesis is 
about; figuring out what ethical implications there might be in digitized measures taken in 
order to accommodate patients suffering chronic disease. To clarify, this section will be used 
to address the actual findings and outlining details of the case, while the later section in 
regard to ethical implications and the discussion of these will address the ethical implications 
found in the case material. Thus, the focal point of this section will be more towards the 
actual case findings as presented by the researchers of Case One, and less towards ethical 
discourse.  
 
6.1.1 Rationale and Needs Analysis Underlying for Case One 
 
The very first details that are disclosed in Case One is that Cognitive Behavioral Therapy 
(CBT) is considered one of the most proficient ways of treating one of the most 
commonplace chronic pains war veterans experience, namely chronic low back pain. The 
problem, however, is that currently only half of Department of Veteran Affairs (DVA) are 
able to afford and therefore have access to trained CBT therapists. The standardized method 
for treating low back pain would typically consist of 10 weekly hour-long sessions, with 
some patients requiring more extensive contact and accommodation and others slightly less 
(Piette et. al., 2016). 
 
Case One defends the view that these treatment requirements are inadequate in terms of 




“A review of data for veterans receiving outpatient opioid prescriptions showed that 
less than half received any mental health treatment, and a survey by VA’s National 
Program for Pain Management found that half of VA facilities did not have any pain-
focused psychological services such as CBT.” (Piette et.al, 2016, 15) 
6.1.2 Cognitive Behavioral Therapy (CBT) supported by Artificial Intelligence (AI-
CBT) 
 
A fair critique to Case One would be that the case doesn’t necessarily explain and dive into 
the defining factors of what classifies as Cognitive Behavioral Therapy (CBT), even though 
accommodating war veterans with a more effective treatment through an alternative way of 
treating low back pain through CBT is the main premise of the Case One medical trial. 
Consequently, we may need spend some time explaining what generally defines CBT as a 
treatment method, and then compare and contrast CBT with the new proposed method of 
treating low back pain as suggested by Piette et.al (2016) in this research article on 
accommodating chronic low back pain in the DVA. In fairness to Case One, the general 
terms of what defines as CBT is quite broad being that it is a technique used to treat a wide 
spectrum of different psychotherapy-related problems, be they chronic or temporary or, 
physical or mentally oriented. Such spectrum could range from diagnoses like depression, 
anxiety, Post Traumatic Stress Disorder (PTSD) or, as Case One describes, chronic low back 
pain. Therefore, it is understandable that Case One refers to the specific parameters that 
define the standardized approach within the DVA in dealing with chronic low back pain. That 
said, for the purpose of understanding CBT properly as a psychotherapy treatment, the 
objective now will be to address the general defining factors that attain to the term CBT, to 
broaden our understanding of why this specific treatment was the deciding factor in treating 
war veterans suffering from chronic low back pain. 
 
Cognitive Behavioral Therapy (CBT) is described as a treatment that focuses on conversation 
and guidance through face-to-face conversations with a trained psychotherapist, or, 
alternatively, as described in Case One through automated messages that adapt to a patient's 
physical and/or mental condition. Most commonly it is used to treat mental disorders such as 
different stages of anxiety and depression, but also works for more physical health related 
issues. Setting aside Case One, CBT does not necessarily rely on artificial intelligence as is 
the case for Case One, but rather face-to-face conversations. According to Piette et al. (2016) 
 
 41 
the traditional face-to-face therapy sessions were deemed more costly and time consuming as 
it requires the physical presence and expertise of individual trained physicians to give 
guidance, often in the context of therapy sessions, which is not necessary for Case One being 
that the chronic back pain is a physical health problem, rather than a mentally oriented one, 
so guidance did not have to include human contact. (Piette et al., 2016) 
 
However, when the health problems are more mentally oriented, which is not the case for 
Case One, face-to-face conversations are important because patients with mental deficiencies 
frequently show reduced risk of depression and anxiety, according to Bergland (2016) who 
cites an October 2015 study (Teo et. al, 2015). 
 
After carefully reviewing the 2015 study published in the Journal of the American Geriatrics 
Society, Bergland (2016) concludes with the following statement (Bergland, 2016). 
 
“The researchers found that having limited face-to-face social contact nearly doubles 
someone's risk of having depression. Study participants who met in person regularly 
with 3family and friends were less likely to report symptoms of depression, compared 
with participants who emailed or spoke on the telephone.” (Bergland, 2016) 
Additionally, the sentiment that mental deficiencies requires therapy sessions in a face-to-
face format is supported in a press release (Bergland, 2016) as lead author and assistant 
professor of psychiatry at Oregon Health & Science University Alan Teo claims the 
following statement, underlying the contrast in face-to-face conversation therapy versus 
socialization through digital communication and phone calls - which is essentially what Case 
One describes as its premise.  
 
"Research has long-supported the idea that strong social bonds strengthen people's 
mental health. But this is the first look at the role that the type of communication with 
loved ones and friends plays in safeguarding people from depression. We found that 
all forms of socialization aren't equal. Phone calls and digital communication, with 
                                               
3  Bergland (2016) describes that the importance of face-to-face conversation is necessary due to its 




friends or family members, do not have the same power as face-to-face social 
interactions in helping to stave off depression." (Teo, Press Conference) 
 
This ultimately supports the theory as suggested by Piette et.al (2016) that physical health 
problems do not necessarily require physical consultations with therapists, which contrasts 
with mental deficiencies as social contact is part of the treatment to cure mentally oriented 
issues. 
 
6.1.3 Identifying the Problem and Consequences of Chronic Low Back Pain 
 
Musculoskeletal disorders are highly prevalent among VA patients, with chronic back pain 
being the most reported type of health issue related to musculoskeletal disorders (Sinnott & 
Wagner, 2009, 1338–1339). VA data shows that there is an annual 4.8% increase per year in 
low back pain since war veterans are aging and therefore experiencing musculoskeletal 
disorders as bone density decreases, but also because of an increasing prevalence of obesity 
(Sinnott & Wagner, 2009, 1338–1339). The problem, which Case One highlights as one of 
the most prominent issues related to treating this, is that the cost of treating back pain in the 
VA is estimated to be about $2.2 billion annually4, using the CBT approach for treatment that 
relies on costly therapy sessions with trained professionals, and not the AI-CBT approach as 
suggested by Case One. There are several reasons as to why one would want to tend to 
chronic low back pain, but the most prominent symptoms associated with chronic low back 
pain are work interruption, emotional distress and risky health behaviors such as substance 
use to ease the pain (Piette et al, 2016). Emerging evidence also 5suggest that chronic pain 
may hinder or compromise successful treatment and management of other chronic conditions 
(Krein et al, 2007, 61-68). The need for Case One’s AI-CBT treatment is even more 
pronounced as the research article references research on opioid medications, which is a 
common way of treating chronic pain, but their use can lead to serious adverse effects (Piette 
et al., 2016).  
 
                                               
4 VA data affirms that treating chronic back pain costs $2.2 billion annually prior to the AI-CBT 
approach (Yu et al, 2003, 146-167) 
5 VA data affirms that chronic low back pain is increased by 4.8% annually (Sinnott & Wagner, 2009) 
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6.1.4 Mobile Health (mHealth) as a Self-Management Platform for Chronic Patients 
 
Case One affirms that mHealth services typically have low marginal costs, meaning they can 
reach out to many patients on a low budget. In fact, there has been more than 50 studies that 
confirm through a demonstrative process that patients are able to use mHealth tools 
sufficiently and provide information to physicians (Piette et. al, 2016). However, Piette 
(2016) states, the implications of using mHealth are that these types of tools often consist of 
simplistic series of messages based on predetermined “if-then” algorithms. Patients report 
that CBT therapy through mHealth Tools can often feel “robotic” to users, causing the 
benefits of standard CBT to diminish after patients end their therapy. (Piette et. al, 2016, 4).  
 
By looking at this, one can argue that autonomous behavior is typically cost-efficient, but 
may feel robotic to some as it does not involve social contact with other human beings. It 
seems that predetermined algorithmic like behavior must be approached carefully, because 
users may disengage if the messages become simplistic in its ability to interact with and 
engage the user.  
 
Case One takes this into consideration by stating that it attempts to test a model that will take 
advantage of the cost-efficiency of mHealth Tools, while at the same time ensuring that CBT 
therapists and trained professionals have integrated the treatment model with sufficient 
information, with the hopes of being more engaging as the quality of messages and guidance 
is increased. 
6.1.5 Outline of the Conceptual Approach Used to Analyze Case One 
 
Lastly, in analyzing the background for Case One, we may need to address more directly its 
conceptual framework. Piette et. al (2016, 4) states that the intervention, which Case One will 
evaluate, is based on widely adopted evidence-based models of CBT, also referred to as 
traditional CBT, and is linked with a personalized care and-self management system using 
reinforcement learning (RL). This is the reason why the article refers to Case One’s CBT 
treatment process as AI-CBT, being that RL relies on artificial intelligence, meaning in this 
specific application case that it incorporates an “intelligent agent” designed to learn what 
treatment choices work best to optimize a measurable outcome (Piette et. al., 2016, 4). Case 
One stresses the fact that reinforcement learning in this case is used in order to attain 
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information about chronic low back pain through an adaptive system that collects patient data 
depending on physical movements through a pedometer, rather than the patient receiving 
guidance and learning self-care skills through the intervention of using the AI-CBT. 
 
In fact, the algorithmic behavior displayed in the RL system has its basis in consumer 
targeting programs such as Netflix, Google and Amazon (Piette et. al., 2016) as it learns 
automatically what information is the most relevant for the target user. 6 
 
Figure 1: The Reinforcement Learning Feedback Loop. “The AI-CBT actions are the 3 CBT session types; the 
is IVR-reported pedometer step counts, and state data is IVR-collected information on patients CBT skill 
practice and pain-related functioning.” (Piette et. al., 2016) 
 
6.1.6 Methods Used to Design and Implement Case One 
 
The method used to successfully and sufficiently complete Case One relies on a comparison 
between standard pain CBT with an innovative strategy that uses mobile health technology 
and AI in conjunction with people that are trained professionals, Piette states. The trained 
professionals will deliver evidence-based and stepped therapy with the intent to cure chronic 
low back pain, and result in the research program being both cost effective and sufficient in 
terms of the information parameters inserted into the AI provided by trained therapists.  
 
There will be a total of 320 patients participating in the study, all suffering from chronic low 
back pain. These patients will be recruited from 2 active VA health care systems and 
randomized to a standard of 10 sessions of telephone CBT and AI-CBT. Patients are split into 
                                               
6 Reinforcement Learning (RL) is a field of artificial intelligence that uses adaptation as its model to 
reinforce its behavior and strengthen it through an individual, or “intelligent agent” (Piette et.al., 2016)  
 
 45 
two camps, one which primarily focus on the results of standard CBT therapy sessions and 
one camp that result to AI-CBT as the treatment of choice to accommodate their chronic low 
back pain. (Piette et al., 2016, 1) 
 
All of the 320 patients will begin with a weekly telephone counselling session, however the 
patients in the AI-CBT camp that report a significant response will be stepped down and put 
on a less resource intensive alternatives, which include (1) a 15 minute conversation with a 
therapist, and (2) CBT clinician feedback provided by interactive voice response calls7 to the 
patient, also referred to as IVR. (Piette et al., 2016, 1) 
 
The AI engine will through the IVR calls and pedometer step counts that the patients provide, 
find out what works best in terms of a patients personally tailored treatment plans. These 
results and measurements take place at 3 and 6 months after recruitment. (Piette et.al., 2016)  
 
Specifically, at 3- and 6-months post recruitment is when patients get to report on their 
current levels of pain and if the AI-CBT program has managed to tailor a more effective 
treatment plan for them, if the chronic low back pain patients are satisfied or if patients wish 
to drop out of the treatment program. (Piette et.al., 2016) 
 
6.1.7 Results and Conclusions Drawn from the Pilot Test of Case One 
 
Because the trial is currently in the start-up phase, the results will not be available before the 
winter of 2019, according to Piette. However, one can still draw thought worthy ethical 
8discussion from the procedure and how Case One is currently planned out. These ethical 
implications will be looked at in the ethical evaluation section of this thesis, through the 
framework of Gillon’s four principles of medical ethics (1994). The results in themselves, 
while interesting in terms of how sufficient AI-CBT actually will prove out to be for patients 
suffering chronic low back pain, will not play a determining role in discussing the ethical 
issues that one is able to identify in Case One.  
                                               
7 Interactive Voice Response (IVR) is a therapy session between a trained therapist and a patient 
through the use of a telephone call, focusing on treatment through conversation filled with advice 
(Piette et al., 2016, 1) 
8 In total, 320 patients will participate in “Case One”. They will be divided into two groups, one for 




That said, patient enrolment began in the fall of 2016 (Piette et al., 2016, 1) which means that 
the AI-CBT program has had sufficient time to take shape, but no findings or updated 
information has been added to Case One yet, being that this information will be readily 
available in Winter of 2019. However, these authors claim (Piette et al., 2016, 16) that if 
successful, the study will hopefully be able to establish a new approach for using AI in pain 
care treatments to treat similar chronic diseases. This may be a building block or stepping 
stone to new treatments if the same method of extracting data through adaptive AI is applied.  
6.2 Case Two: Mobile Health Devices as Tools for Worldwide 
Cardiovascular Risk Reduction and Disease Management 
 
Piette and al. (2015) describe an earlier measure taken to better accommodate patients with 
cardiovascular diseases in the form of preventive measures taken through a digitized 
procedure. 
 
Case Two (Piette, et. al. 2015) exhibits quite different characteristics from Case One, as it is 
essentially a review of grey literature, as well as peer-reviewed literature, on cardiovascular 
disease prevention in mHealth Tools. However, Case Two stands out because it is essentially 
not a case that follows a procedure and shares its findings through said procedure, but rather a 
review of literature and findings.  
 
The next generation mHealth programs should be based on evidence based on behavioral 
theories and incorporate advances in artificial intelligence for adapting systems (Piette et. al, 
2015). This is interesting, because it points to an autonomy model that further points the 
responsibility on patients. Another interesting ethical challenge we are going to uncover and 
pay special attention to as we analyze Case Two would be that the study is worldwide, 
meaning it also focuses on assessing the situation of how mobile health devices as tools to 
accommodate cardiovascular disease reaches low to middle-income countries. This is 
interesting because it points to Gillon (1994) and the four principles of medical ethics, one of 
them being justice. How is cardiovascular disease management and risk reduction handled 
and treated in low to middle-income countries? To find out if there is just treatment and if the 
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ethical principles are upheld, we will start by analyzing the findings and details of Case Two 
now. 
6.2.1 Challenges Posed by Cardiovascular Disease (CVD) 
 
Cardiovascular disease (CVD) is a massive issue and is in fact the leading cause when it 
comes to global deaths, being that it is responsible for 30% of all deaths in the world. 
Treatment and risk reduction in CVD often depend heavily on how people manage their 
condition, and doctor visit at the local health care provider is a crucial factor in determining 
how well the patient is treated. When it comes to self-management there is a significant 
challenge to treat patients because such a thing requires that patients are disciplined in 
following a strict medication regime, understand their own condition and when it worsens 
and being in charge of their own lifestyle behavior changes such as physical activities and 
maintaining a healthy diet. Especially in low income countries, health care physicians and 
resources are scarce, meaning that it remains a challenge to provide sufficient interaction 
with patients suffering from CVD. The opportunity to take advantage of patient–centered 
health communication technology is therefore a promising evolution in the approach to 
provide patients suffering from cardiovascular disease a sufficient follow-up system that 
works both in terms of being cost-effective, and also provides a more extensive reach due to 
the cost-effectiveness of the treatment. (Piette et al., 2015, 1-2). 
6.2.2 Claims to Address the Limitations of Health Systems in Low- and Middle-
Income Countries 
 
Giving patients an option to receive proper health care to treat CVD is even more important 
in low- and middle-income countries (LMICs). Patients in LMICs often face costs that are 
not regulated in a sufficient manner, and thus being too costly for patients in LMICs to 
afford. Another crucial reason is that patients suffering CVD in LMICs often work jobs that 
cannot provide financially in terms of their health care budget. Piette et. al provide relevant 





9” A World Health Organization survey of >256 000 respondents in 70 countries 
found that health care accounted for 13% to 32% of household expenditures, and cost 
barriers were a frequently cited reason for inadequate chronic illness care.” (Piette 
et. al, 2015, 2)  
 
In some situations, the patients of health services in LMIC may afford the treatment, but it is 
often the case that the treatment is insufficient in terms of quality or just unavailable (ibid, 
2015, 2). Judging by the statistics of the World Health Organization, the deficit in health care 
providers are beyond 4 billion, and 57 countries experience significant shortages. There has 
been a number of healthcare professionals leaving LMICs to find jobs in countries because 
LMICs have poor training in preventing and managing cardiovascular disease. (ibid, 2015, 2) 
 
This opens up mHealth as this is a far more cost-effective and less physically-demanding tool 
that could potentially revolutionize the way cardiovascular disease is accommodate through 
expensive and often misinformed consultation with trained professionals.  
6.2.3 Mobile Health as a Partial Solution 
 
Through innovative thinking and through the use of mobile health technology, researchers of 
Case Two have found that mobiles may be a central tool in addressing the barriers to CVD 
prevention and management. Currently there are about 6 billion mobile phones users 
worldwide (Clark et al., 2007, 942-950) and with about ¾ out of those currently residing in 
LMICs. Going by these statistics, one can determine that the frequent use of cell phones 
present an opportunity to use this as a resource for behavior change in managing CVD, which 
is supported by evidence that demonstrates how telephone therapy sessions will improve a 
patient's current health situation (Piette et al., 2015, 2).  
 
There are more than 6 billion mobile phone users worldwide with almost three-quarters living 
in LMICs. The explosion in cell phone use represents an important resource for lifestyle 
change and disease management, because abundant evidence has demonstrated that telephone 
follow-up improves the quality and outcomes of care. Piette et. al. (2015, 2) states in Case 
Two that most of the research done so far in the effectiveness of using mobile phones in 
                                               
9 A World Health Organization survey of >256 000 respondents in 70 countries found that health care 
accounted for 13% to 32% of household expenditures. (Piette et  al., 2015, 2) 
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accommodating health problems have been done in high income countries (HIC), but one can 
find promising health related results in accommodating chronic diseases such as controlling 
glycemic control and telephone therapy for patients with heart failure.  
 
“Although most trials of telephone care have been conducted in high-income 
countries (HICs), investigators in Chile reported that low-income diabetic patients 
randomly assigned to telephone nurse counseling had better glycemic control than 
patients receiving usual care, and postdischarge telephone support for patients with 
heart failure in Argentina significantly reduced readmission rates relative to 
randomly assigned controls.” (Piette et al., 2015, 2) 
 
Unfortunately, however, in the case of telephone related health management, it is difficult 
sometimes to demonstrate the actual cost savings that companies look for if they are to invest 
human capital in telephone related health tools such as mobile health tools. Piette et. al (2015, 
2) describes this in Case Two as he refers to a review of 15 randomized trials with the intent 
of managing chronic disease through mobile health tools. The trials with a total of 18 000 
patients suffering chronic disease concluded that only a total of 2 studies provided evidence 
for sufficiently lower costs. (Peikes, 2009, 603-618). 
  
In discussing Case One (Piette et al, 2016), we might find the partial solution to the difficulty 
in maintaining a low budget in telephone follow-up for accommodating chronic disease, as 
we have already discussed the potential of mHealth tools and how using adaptive algorithms 
will save a health care provider a significant amount of work and be a better financial 
decision than therapy consultations. Hence, in order to meet the two-sided goal of both 
having a low-cost option to follow up patients suffering from CVD and also provide 
sufficient and quality treatment, Case Two (Piette et al., 2015, 2) argues the same as Case 
One argues. mHealth is superior in the fact that it is able to provide positive impacts on 
patient well-being, although significant implications and barriers remain if were to introduce 
this technology in LMICs.  
 
mHealth interventions take a variety of forms, each with its own benefits and limitations in 
terms of the specific modalities reach and the richness of the information exchange. 
Interactive voice response (IVR) calls allow patients to receive information and communicate 
with others asynchronously using their mobile or landline telephone. Using IVR, patients 
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interact with a structured series of recorded message components and respond to queries 
using their touch-tone keypad or voice-recognition technology. Based on their responses, 
patients can receive recorded messages tailored to their individual needs. Clinicians can 
receive automated updates based on patients’ responses during IVR calls, along with 
structured feedback about how to improve disease management. Patient-directed short 
message service (SMS) or text messaging interventions are designed to improve disease 
management primarily through reminders that improve adherence to behavioral goals such as 
medication taking, and through educational or supportive messages that increase motivation 
for changes in lifestyle behaviors or self-care. SMS messages can be triggered automatically 
or by clinicians, and some services use bidirectional communication with patients to increase 
program engagement and service impact. More recent advances in mHealth include 
smartphones and other mobile communication tools enabled with graphical screens, video, 
audio, and Internet access. An advantage of smartphones is that structured information from 
patients can be collected through a touchscreen or voice recognition system, thereby allowing 
more accurate and extensive patient reporting than is possible with SMS. Global positioning 
systems and physiological sensors can be added to further tailor health communication and 
monitor patients’ status. The widespread and growing use of social media such as social 
network sites, blogs, wikis, Twitter chats, photo/video sharing services, and virtual worlds 
represent additional opportunities for engaging patients via their smartphone. In particular, 
new social media can extend the reach and impact of social networks, enable sharing of 







Figure 2: Illustration of Three mHealth Services Targeting CVD. “Examples of mHealth services targeting 3 
levels of cardiovascular disease prevention and management. CVD indicates cardiovascular disease; IVR, 




6.2.4 Interactive Voice Response 
 
Trials conducted in HICs have shown that IVR-based interventions can be effective in 
promoting physical activity, improved dietary behavior, and smoking cessation. A trial of 337 
blacks with hypertension found that 32 weekly IVR calls improved overall dietary quality 
and energy expenditures relative to controls who also received a resource manual and a 20-
minute in-person health education session focused on lifestyle behaviors. A study of an IVR-
delivered intervention focused on family goal setting and changes in the home environment 
showed improvements in obese children’s level of physical activity, dietary behaviors, and 
body mass index. In a diverse low-income sample of patients with diabetes mellitus, 
investigators found that an IVR service coupled with nurse care management achieved 




6.2.5 SMS or Text Messaging 
 
With 5800 participants, the SMS smoking cessation program (txt2stop) trial sought to 
improve smoking cessation rates in the United Kingdom through a series of motivational 
messages. Patients were randomly assigned to receive motivational SMS messages or 
messages unrelated to smoking. Txt2stop more than doubled biochemically confirmed quit 
rates at 6 months relative to controls. Studies of SMS interventions focused on promoting a 
healthier diet, weight loss, and physical activity in HICs have shown mixed results. One US 
trial using daily SMS messages focused on tailored dietary goal setting and showed 
significant improvements at 4 months in eating behavior and body weight. However, an SMS 
intervention incorporating pedometer step-count feedback among adolescents with diabetes 
mellitus did not increase physical activity. A trial focusing on promoting weight maintenance 
after a 3-month behavioral weight loss program through bidirectional and tailored SMS 
messages found no overall benefit over the subsequent 9 months in weight, eating behavior, 
or psychological mediators of behavior change. Despite relatively high adherence among 
adult participants in an interactive and personalized weight management program, 
investigators found no between-group difference at 6 and 12 months in weight when 
comparing groups receiving SMS messages versus a monthly e-newsletter. However, SMS-
group participation did increase users’ pedometer-measured physical activity levels, and 
greater activity and text messaging adherence were associated with greater weight loss. 
Research currently underway may further elucidate the potential of SMS for promoting 
meaningful lifestyle behavior changes that are important for cardiovascular risk reduction. 
Studies including SMS interventions have been conducted in more than 30 countries, 
including several LMICs. A trial conducted in Hong Kong found that SMS messages focused 
on diabetes mellitus–related lifestyle modification reduced rates of progression from 
prediabetes to diabetes mellitus over 12 months. Many mHealth studies in LMICs have 
focused on human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome 
(AIDS); 2 large randomized trials in Kenya found that SMS reminders improved adherence 
to antiretroviral therapy, and 1 trial also reported reductions in viral load among patients 




6.2.6 Case Two: Summary and findings 
 
Although not all studies have had positive outcomes, several randomized controlled trials, 
including 2 studies from LMICs, have shown that IVR interventions can improve lifestyle 
risk factors for cardiovascular disease and disease management, as well. An advantage of 
IVR self-management support programs is that they can be used with any standard cell or 
landline phone. Because no reading or writing is required, IVR interactions are accessible to 
low-literacy populations, and to those with vision problems. Patients can use IVR to report 
detailed information about their status and receive tailored feedback about their health and 
self-care. However, IVR interactions typically require patients to participate when the call is 
placed or to call in to the system. Although patients sometimes can specify when they are 
likely to be available, changes in their schedule may be difficult to accommodate. Unlike 
texts, images, or website links sent to patients via a smartphone, patients using IVR cannot 
review information after the fact. Unfortunately, because of the diversity of study 
populations, outcomes, and IVR system designs, we still cannot identify the characteristics of 
interventions that are associated with greater behavioral change and health improvements. 
Evidence also is growing about the effectiveness of SMS interventions in improving 
behavioral risk factors and cardiovascular disease management, especially interventions 
enabling real-time feedback, exchange, and support. Most randomized trials of SMS 
interventions for chronic disease behavioral change have been conducted in HICs, however, 
and little work to date has examined different behavioral approaches to intervention design or 
content development. Also, there is little known about the optimal dosing, frequency, and 
content of text messages, the duration of interventions, or the individual and group 
characteristics that may identify patients most likely to benefit. An advantage of SMS 
interventions is that they can be used with almost all mobile phones, and they take advantage 
of the widespread use of texting both in HICs and LMICs. However, SMS services are 
difficult for individuals with limited vision, dexterity, or literacy, all of which are more 
common in poor communities. SMS self-care supports tend to be less interactive than 
counselling by a clinician, but when patients are asked to confirm receipt of texts, 
interventions may have increased engagement and impact. More complex 2-way SMS 
messages may boost engagement and effectiveness, but this may require a clinician or other 
live person to be in the loop, because computers are challenged by the nonstandard spelling 




Newer mHealth interventions hold considerable promise, but the research base on 
interventions delivered via smartphones or social media is still small. In the next few years, 
results from ongoing trials will help to develop the evidence in this important area. The 
advantages and disadvantages are varied depending on where the treatment is funded, as 
LMICs often display implications in funding treatments SMS, IVR or mHealth while HICs is 
often more adaptable in terms of budgeting and can afford to manage chronic diseases using 
SMS, IVR or mHealth. While the important variable if a digital health accommodating 
system is sufficient is often funding, there are overall conclusions to be made in terms of the 
actual effectiveness of the tools themselves as well. In conclusion, perhaps the most lacking 
digital accommodation system is Smartphones and Online Tools, as it is both expensive and 
requires more from the patients in terms of literacy and the complexity of the interaction. 
 
6.3 Case Three: “In Their Shoes” by Takeda 
 
Case Three is an app developed by Takeda, a pharmaceutical company based in Japan, 
Tokyo. The intended purpose of the business is to innovate the health market by serving the 
needs of patients and physicians worldwide. In a recent project the pharmaceutical company 
has attempted to simulate what it’s like to be an Irritable Bowel Disease (IBD) patient 
through the use of a mobile app with the purpose of getting insight into the everyday life of 
an IBD patient.  Employees of the company have participated in the experiment by taking use 
of the app in everyday situations, while Takeda has also shipped the tools needed to 
participate in the simulation project to volunteers contacting Takeda in order to assess the 
experience. 
 
The strategy underlying Case Three is original and potentially disruptive as it does not only 
portray information and accumulate findings about IBD itself but simulates the difficulties 
IBD patients may experience in a real-life situation. By presenting real life scenarios using 
tailored messages suggesting what the app-user must do next in order to accommodate for 
their IBD symptoms, the app-user, in this case employees at Takeda, have challenged 
themselves in order to gain true insight into the everyday life of an IBD patient. The 
participants in the experiment reported their encounter with “In Their Shoes” as a quite 
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stressful experience, as they would have to respond accurately to messages they would 
receive through the app they were given, e.g. messages about when to go to the bathroom and 
such were received frequently, and the participants would need to take precautionary 
measures that they otherwise would ignore in their day-to-day activities, such as always 
being close to a nearby bathroom in case they would get a message saying they have to go to 
the bathroom.  For an IBD patient, symptoms such as spontaneous bathroom visits are quite 
frequent. In fact, it is quite commonplace for IBD patients to research locales for bathroom 
opportunities prior to events or meetings, so that they can fluently find a nearby bathroom if a 
situation causing stomach upset might occur. The constraints and annoyances experienced by 
real-life IBD patients are imposed on “In Their Shoes” participants, who have agreed to 
follow the instructions of the app.  
 
This study analyses the ethical dilemma and the stress put on IBD patients who need to be 
excused in various social settings, which can, depending on the situation and individuals 
involved, appear as inappropriate, in contrast to social norms, or psychologically diminishing. 
Interestingly, the participants in the “In their Shoes” experiment were quick to realize that the 
social pressure felt in situations like those described above are ethically questionable. This 
app-based experiment gave ordinary people the ability to experience and appraise the 
pressure of a situation which a typical IBD patient frequently experiences, opening for the 
discussion about social norms and how one should deal with situations were IBD patients 
experience social distress because they must leave social gatherings or meetings due to 
emergent issues related to their IBD. 
 
It can be argued that what Case Three lacks in terms of academic credibility, it makes up for 
in the unorthodox approach it makes in its method to inquiry information about IBD. Case 
Three simulates a disease and the stakeholders of Takeda are the ones undergoing medical 
procedure that Takeda initiates. This is the reason why the choice to include Case Three, 
despite its shortcomings in amount of information displayed in the outlining, was made. 
Because Case Three is a simulation to acquire information, it completely revolutionizes the 
ethical principle of autonomy in the way information circulates, being the participants 
(stakeholders of Takeda) are also the recipients of the information, making the medical 
experiment fully autonomous in the way information is acquired.   
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7 Analysis of Ethical Implications in Each of the Three 
Reviewed Cases 
 
In this chapter of the thesis the intention is to address certain ethical implications central to 
the three cases and use the four principles of ethics in medicine (Gillon, 1994) as a 
framework in the analysis of each given ethical implication. The four principles of medical 
ethics will be used as a basis in this section because the intention will be to evaluate the cases 
based on justice, non-maleficence, level of beneficence and the level of autonomy, focusing 
mostly on the one principle that applies to the ethical implication in each respective section.  
7.1 Case One: “Patient-Centered Pain Care Using Artificial Intelligence 
and Mobile Health Tools: Protocol for a Randomized Study Funded 
by the US Department of Veterans Affairs Health Services Research 
and Development Program” 
 
Case One, as we refer to it in this thesis, brings forth numerous ethical implications that will 
be address in this section, using the information described in the presentation of cases -
section of this thesis and the four principles of medical ethics applied to each ethical 
implication in order to see if the case has complied with the four principles of medical ethics 
or not.  
 
Because the results of Case One will not be concluded before the winter of 2019, the ethical 
implications derived from the case might change as patient enrolment and results take shape. 
However, the abstract of the measure and the actual procedure of how the measure is going to 
be conducted is interesting, as it is the act of conducting such research that is interesting, and 
not necessarily the results of the research. The reason why one does not necessarily need the 
actual results of Case One is because the procedure, method, objective and general way of 







In identifying and discussing justice which is one of the ethical principles of medicine 
according to Gillon (1994) to see if it is upheld or not in Case One, reference is made to an 
article originally published in The Technology Source and authored by Timothy VanSlyke, 
“Digital Natives, Digital Immigrants: Some Thoughts from the Generation Gap” as VanSlyke 
(2003) shares some much needed knowledge regarding the generation gap in his review of 
literature such as the contribution of  Prensky (2001) regarding the ‘digital natives’ which 
describe the younger, more adaptable generation and the ‘digital immigrants’ describing the 
generation that was not born with the same amount of information and instant gratification as 
the digital natives, typically born in the 1990s (VanSlyke, 2003).  
 
It appears what VanSlyke (2003) describes is especially relevant in Case One, as the average 
age of U.S veterans is a strong factor of adoption/rejection of assistive technologies, e.g., how 
various U.S veterans relate to procedures involving digital solutions, may depend strongly on 
age variables. Understandability of technology is often highly dependent on developing a 
personal relationship to digital tools and on the frequency of use. Such an age-dependent key 
factor would put U.S. war veterans, whose average age are between 65 and 74 years old10, at 
a disadvantage, as they are more likely to experience difficulties in complying to and 
adjusting to the use of digital tools than the younger generations. In general, the younger 
generations would have a closer and more personal relationship to technology and therefore 
would be able to relate to such measures more easily, than those who grew up without the 
Internet. The Internet more and more reflects humanity and becomes increasingly 
individualized, as reflected by thoughts from Prensky (2001) in his description of youth - 
described as digital natives - and how they relate to information. 
 
“Digital Natives are used to receiving information really fast. They like to parallel 
process and multitask. They prefer their graphics before their text rather than the 
opposite. They prefer random access (like hypertext). They function best when 
networked. They thrive on instant gratification and frequent rewards. They prefer 
games to "serious" work. (2001, 1). In contrast, those not born in the digital world 
                                               
10 The average age of war veterans partaking in the Veteran Affairs (VA) according to The 
Department of Veterans Affairs and The United States Census Bureau is between ages 65 and 74. 
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reveal their non-native status through a "digital immigrant accent" that manifests 
itself in a number of ways—printing out a digital document to edit it rather than 
editing it online, for example” (Prensky, 2001, 4). 
 
Having affirmed that there might be an implication in war veterans adapting to the AI-CBT 
approach described in Case One due to it being quite technically complex and possibly not 
very suited for war veterans who average an approximate age of 65 to 74, we can invoke the 
four principles of medical ethics as described by (Gillon, 1994) to address this issue.  
 
In terms of information provided by a healthcare provider being understandable and 
approachable by the patients involved in the study, the most central principle in medical 
ethics to invoke would be the ethical principle of justice in medicine. For the sake of the 
thesis, we are going to revise this principle and repeat that the ethical principle of Justice in 
medical ethics is dependent on fair treatment for all the participants of a new treatment. 
(Gillon, 1994) It also states that the treatment must be according to the law that constitutes 
the health regulations in each country. Having said that, the question remains for Case One if 
fair treatment according to the principle of Justice found place in how war veterans were 
treated - as described by the case. 
 
The hypothesis in this thesis is that fair treatment did take place, as a priori information 
regarding the scope of the medical experiment was provided to the patients, and patients 
could report back with feedback or decide to drop out voluntarily in month 3 and 6 of the 
study (Piette et al., 2016, 1). However, the implication of the generation gap was not 
mentioned or given consideration in the description of Case One, and as evidence by Prensky 
(2001) and the literature on the generation gap implication, the ethical principle of justice was 
not upheld in Case One. In fact, there was little mention of the average age of war veterans 
and how this could impact the study in Case One, with little to no consideration that age may 
be a determining factor in how patients respond to the treatment.  
 
In terms of the other ethical principles surrounding medicine, namely non-maleficence, 
beneficence and autonomy, the overall consensus based on analysis of the AI-CBT approach 
in Case One is that Case One took these principles into consideration and represented the 
patients’ rights sufficiently. For the sake of this thesis and its scope, it is more important to 
determine if there was insufficient representation in any of the ethical principles (justice), 
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being that evaluation of ethical implications in accommodating patients suffering chronic 
diseases is the scope of the thesis.  
 
However, it is worth explaining just how the other principles apart from justice was taken 




To uphold the four ethical principles in medicine one must first of all consider non-
maleficence, which is saying that a medical procedure must be provided with the intent of not 
doing harm to the individual partaking in the procedure (Gillon, 1994, 185). The level of non-
maleficence in the study can be considered to be sufficient, being that in the feedback period 
in which patients were allowed to provide feedback, no patients reported worsening of their 
chronic low back pain condition as a result of partaking in the study. In fact, interviews were 
done in order to ensure that the patients were satisfied with their current level of pain 
management, making the level of non-maleficence in Case One satisfactory regarding the 
four principles of medical ethics (Gillon, 1994). In Case One, the authors state the following 
to affirm this statement:  
 
“The focus of patient interviews will be on satisfaction with pain care, barriers and 
facilitators of pain management, and motivation for making behavior changes using 
automated systems. AI-CBT patient interviews will focus on patients’ satisfaction with 
the adaptive intervention and the extent to which patients felt that it was able to 
provide them with the care they needed while using their time effectively. “ (Piette et 
al., 2016, 16) 
 
That said, it would be fair to delay judging Case One by the level of non-maleficence as the 
final results will be available towards the end of 2019, which means it is an ongoing research 






In terms of beneficence being upheld in Case One, and for the reader to ease more into the 
context of what that is about, there will be a quick recitation of what it means to uphold 
beneficence as one of the ethical principles in medicine when conducting a study. 
Beneficence, in this context, describes that the procedure must be done in order to benefit the 
patient and provide good results for the patient, rather than, e.g. a net benefit for the 
healthcare provider that issuing the procedure. It claims that the procedure must be for the 
better good and provide net benefits. A patient's rights and individual situations must be 
considered in the start-up process of the procedure and during the procedure and adapted if 
deemed necessary. When discussing if this ethical principle of medicine was taken into 
consideration, we can look to how patients were carefully and respectively invited to join the 
research project through giving their consent over mail as described by Piette et al.:  
 
“After obtaining agreement from patients’ primary care providers, a letter will be 
sent to veterans informing them about the study and inviting participation. Veterans 
who do not opt-out by postage-paid response card will be called by research staff to 
explain the study, conduct screening, and solicit their involvement. If the veteran is 
willing, s/he will be sent the consent form by mail along with a postage-paid return 
envelope.” (Piette et al., 2016, 7) 
 
Another way the principle of nonmaleficence was upheld was through a long list of 
requirements veterans had to meet to be included in the study, taking precautions regarding 
health issues that may have been a problem in affecting the trials and procedures of the AI-
CBT program. (Piette et al., 2016, 7) 
7.1.4 Autonomy 
 
In this section the intent will be to speak on the level autonomy that is practiced in Case One. 
The notion of autonomy is relevantly described by Gillon: 
 
“Respect for autonomy is the moral obligation to respect the autonomy of others in so 
far as such respect is compatible with equal respect for the autonomy of all 
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potentially affected. Respect for autonomy is also sometimes described, in Kantian 
terms, as treating others as ends in themselves and never merely as means-one of 
Kant's formulations of his "categorical imperative.” (Gillon, 1994, 185) 
 
Autonomy, following this author, describes the fact that one must respect individuals as 
individuals, and not mere objects, or e.g., “clinical cases”. This approach was adopted 
convincingly in Case One, for numerous reasons. First and foremost, patients were given 
respect and treated as individuals by allowing them to decline the treatment and overall 
project and essentially giving the patients, also described as consent and the right to choose to 
be involved or not, by Gillon (1994, 185). Gillon (1994) describes this relevantly in his 
description of autonomy with regards to patients consent. 
 
“In health care respecting people's autonomy has many prima facie implications. It 
requires us to consult people and obtain their agreement before we do things to 
them-hence the obligation to obtain informed consent from patients before we do 
things to try to help them. “(Gillon, 1994, 185) 
 
7.2 Case Two: Mobile Health Devices as Tools for Worldwide 
Cardiovascular Risk Reduction and Disease Management 
 
In this part of the thesis I will discuss the ethical implications found in Case Two through the 
same framework described in unveiling of ethical implications in Case One, namely the 
ethical principles of medicine by Gillon (1994). We will find that Case Two share many of 
the characteristics as Case One but is different because it analyses peer reviewed literature 
and grey literature. Interestingly, the review of literature opens for even more ethical 
implications to discuss as there are a multitude of cases described in Case Two.  
7.2.1 Justice 
 
Following the four principles of medical ethics by Gillon (1994), it is evident that Case Two 
especially builds on the ethical issue related to justice. The reason to include the ethical 
principle of justice is because it is evident from the case material that this was a study done in 
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30-50 low to middle income countries (Piette et. al., 2015, 5). Because the ethical principle of 
justice in medicine describes sufficiently reaching out to all patients in medical procedures, 
regardless of an individual's traits, e.g., wealth, sex, orientation, race and other describing 
characteristics, and because Case One indeed raises the issue of how LMICs can receive 
sufficient and justifiable medical coverage through various technological tools, e.g., mHealth, 
IVR and SMS (Piette et. al., 2015, 1-21), it can be argued that Case One takes justice as 
governing medical principle into consideration.  
 
In Case Two, telephone care management programs were the main way of being innovative 
in regard to treating patients through mobile health (Piette et. al., 2015, 2), but this turned out 
to be a problem in LMICs because reporting back to the program initiatives regarding the 
cost of the procedure and contrasting it with other methods was found to be problematic or at 
times impossible, as the technology of telephone care management programs typically did not 
support this action of tracking cost-efficiency (Piette et. al., 2015, 2).  
 
Due to this, a solution was mHealth tools using reinforcement learning (Piette et. al., 2015, 
3). In light of this, one could argue that justice is carefully considered as Case Two appears to 
be problem oriented in its approach to find literature and cases that pertains to all patients 
suffering cardiovascular diseases, regardless of it being a HIC or a LMIC.  
 
An ethical implication directly linked to the defining variables of justice as an ethical 
principle in medicine can be found as Case Two addresses issues of language barriers, e.g., 
stating that the “development of mobile health services for language minority patients, e.g., 
the many indigenous communities in Latin America, is an important priority.” (Piette et. al., 
2015, 12). As evident by the description of Case Two previously in this thesis, the authors 
argue that it was indeed a challenge to find literature that consulted this issue of making 
language-friendly technology that could be applied and understood globally, and not just in 
the English-speaking countries. Case Two cannot provide a sufficient solution in its review of 
literature to solve the ethical implication of justice, stating that “more evidence is needed on 






After careful review of the content of Case Two, a logical conclusion would be that there is 
little to no reasons to believe that Case Two has any maleficent intent. The fact that the 
premise of the thesis is to find and review literature with the intention to highlight the current 
research and potential of digitized medical approaches for CVD patients should lead to the 
logical conclusion that it is not maleficent in its scope, method or findings. When it comes to 
the approaches that were reviewed within the article to accommodate patients suffering 
cardiovascular diseases in a digitized manner, one could, however, argue differently.  
 
If one is to argue differently, and state that there might be a level of maleficence displayed in 
the procedures that was reviewed in Case Two to accommodate patients suffering from CVD, 
it is essential to highlight that it is only a possibility, and not a matter of fact. However, as it 
relates to the scope of this thesis, it is worth explaining and highlighting how such maleficent 
intent could occur in procedures attempting to better accommodate patients suffering from 
CVD. 
 
Lupton (2015) is one of those who would probably look at the medical procedures and trials 
reviewed in Case Two and question their intention with respect to the ethical principle of 
non-maleficence, as Lupton (2015) believes that there are several socio-economic and 
political implications of digitized health tools attempting to accommodate patients suffering 
chronic disease (Lupton, 2015, 174-183).  
 
Lupton (2015) states her mis contempt with the idea of self-monitoring digitized health tools, 
which more or less describes every initiative described in Case Two, by stating that we draw 
attention away from the actual symptoms of disease and thus our well-being through the use 
of self-monitoring devices that are increasingly autonomous in their nature.  
 
“What is particularly noticeable about the ways in which digitized health promotion is 
employed in the majority of current programs is that most strategies render health 
states even more individualized, and draw attention away from the social 




Another possible critique that applies to Case Two in terms of the ethical principle of justice 
in medicine, could, as argued by Lupton, 2015, 174-183), be that digitized medical programs 
portray public groups or individuals as incapable of taking care of their own health. Lupton 
(2015, 174-183) argues this point by stating that research critical to the emerging digitized 
approaches of accommodating disease points to a general consensus that these initiatives try 
to pain individuals or social groups as inept in dealing with their own disease.  
 
“They have contended that this focus tends to represent individuals or social groups as 
ignorant, morally deficient and lacking self-control and the capacity to take 
appropriate responsibility for their health if they fail to take up health promotion 
imperatives” (Lupton, 2015, 174-183).  
 
While Lupton (2015) does point to thought worthy critique that could be applied not only to 
Case Two and the literature it reviews, but also to Case One and Case Three being that they 
are both of the same context, it remains to be concluded that the ethical implications of 
justice in terms of socio-economic and political implications described by Lupton (2015) is 
true. However, it is still a relevant and thought worthy discussion, and can shed light on the 
possibility of maleficent intent in procedures that one would not normally consider to be 
maleficent in nature, being that a ‘digitized measure of accommodating patients suffering 
chronic disease’ does not necessarily provoke doubtful intentions.  
7.2.3 Beneficence 
 
Beneficence as described by Gillon (1994, 185) is closely tied to the notion of non-
maleficence, and it is the balance of the two and applying them at the same time in a given 
medical approach, consultation or procedure that is the key to justify the ethical principle of 
beneficence. The overall goal of will always be to provide net-benefit (beneficence) while 
still practicing safe medical approaches and methods to ensure that patients are not hurt, 
mentally or physically, during encounters with health digitization processes or in non-
digitized approaches (non-maleficence) (Gillon, 1994, 185).  
 
In studying Case Two, one can find several examples of beneficence being approached and 
taken into consideration. A common denominator for Case Two is that virtually every 
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digitized measure to treat CVD is focused towards cost-efficiency, because this provides a 
net benefit in terms of how many patients can be reached with each specific digitized medical 
treatment. That said, however, not all the medical approaches to digitized healthcare were 
able to produce a net benefit in terms of cost. As previously learned in the description of Case 
Two, 256 000 respondents in over 70 countries found that health care accounted for 13-32% 
of the household budgets in LMICs (Piette et. al., 2015, 2). This is a significant blow to 
beneficence as 13-32% of a household budget is a rather large number, meaning that in terms 
of costly digitized treatment methods, beneficence as an ethical principle in conducting 
digitized medical approaches in LMICs was not sufficiently justified.  
 
An essential defining factor of beneficence in medical research or in conducting medical 
approaches is that each patients individual needs are respected and incorporated into the 
thought process building on the research enquiry, which can be argued that Case One is 
mostly ignorant of, being that Case Two is more a review of literature about social groups 
and culture’s applicability in terms of receiving medical care through innovative, digitized 
health approaches. In contrast to, e.g., Case One, which focus primarily on one specific type 
of age group and is confined within the DVA, focusing on primarily on treating war veterans 
suffering from chronic low back pain (Piette et. al., 2016, 1). Case Two has a much broader 
range than Case One, e.g., in terms of the review of apparatuses, digitized medical 
approaches, socio-economic factors and cultural factors. The digitized approaches in Case 
Two include SMS, IVR, telephone management consultations, social media information and 
RL, and one can imagine the difficult nature of considering individual patients needs in such 
a wide variety of digitized medical approaches. 
7.2.4 Autonomy 
 
In discussing to what degree Case Two has “respect for autonomy” (Gillon, 1994, 184), it is 
important to understand the defining factors of autonomy and in what degree it takes place 
the digitized practices we see in Case Two. In biomedical ethics, the principle of autonomy or 
as Gillon (1994, 184) describes it, ‘self-rule’, is important as it allows the patient to develop 
an understanding of their own medical condition. A key part of autonomous ‘self-rule’ is 
what McBain et.al (2015, 1) describes as ‘self-management’, using digitized tools or 
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hardware to monitor one's own health, often related to chronic illness where consistent 
monitoring of health-related factors is deemed necessary.  
 
“Self-management has been defined as an individual’s ability to manage the clinical 
and psychosocial consequences, along with the lifestyle changes inherent in living 
with a chronic condition” (McBain et.al, 2015, 1) 
 
Now that we have defined autonomy as self-management or self-rule, an interesting topic of 
discussion related Case Two would be the implication of storing personal data through an 
increasingly monitored and autonomous way of approaching healthcare for patients suffering 
chronic disease. The assistive and disruptive technologies mentioned in Case Two to better 
provide health care in LMICs, e.g., mHealth, SMS-texting motivational messages (txt2stop) 
and IVR are all approaches that can provide health care assistance through awareness and 
information about CVD, but these approaches require that the patients share personal data 
about their health.  
 
This increasingly autonomous way of monitoring and acquiring information about patients 
through various digital health measures pinpoints the implications of misconstruing 
information for financial gain. The argument made against collecting patient health data 
(PHI) through a more autonomous digitized health market in LMICs could be that LMICs 
suffer from a lack of knowledge and understanding of medical conditions due to a lack of 
clinicians with an expertise in CVD-based treatment methods, leaving them vulnerable to be 
exploited and taken financial advantage of, as mHealth, SMS-texting and IVR all collect 
sensitive PHI that could be sold, used and misconstrued to financially benefit private 
companies, namely unregulated software companies that produce apps or pharmaceutical 
companies that sell prescriptions (Thielman, 2017).  
 
Now that we have presented the argument against Case Two and how autonomous self-
monitoring might lead to a misuse of PHI through selling data to unregulated companies, we 
can examine the conducted trials that were performed in Case Two to determine if Case Two 
has a respect for autonomy or not. To do this, one must understand the underlying principles 




“The Health Insurance Portability and Accountability Act (HIPAA) is a federal law 
which governs the use and disclosure of PHI by covered entities, defined as health 
plans, health care clearinghouses, and health care providers who electronically 
transmit PHI.” (Lacktman, 2018) 
 
To address our concern, we must then examine of the trials conducted using digitized health 
measures to accommodate CVD patients (e.g., SMS-texting, mHealth and IVR), corresponds 
with HIPAA. In looking at HIPAA we find that there are different laws for sharing PHI 
depending on which entity is using the PHI, but the general rule for all entities using PHI is 
that all data extracted from a patient must be in correspondence with said patients consent to 
share that data. Because the “entity” we are referring to in Case Two is that of a “research 
trial”, we will examine if the criteria for respecting patient autonomy was met in the way 
Case Two dealt with PHI. 
 
First, Lacktman et.al (2018) describes that if PHI is used in a research process, which is 
correct for Case Two, the providers must do one of the following: (1) receive approval from 
an institutional review board or a privacy board waiver of authorization, (2) receive approval 
from each individual featured in the research trials that were conducted, (3) use the PHI 
through a limited data set or (4) use the PHI and then de-identifying the information so that it 
cannot be reused. Being a review of peer-reviewed literature that addresses different methods 
of accommodating CVD through digitized measures, Case Two does not mention once how 
PHI was acquired and through which process it was affirmed that patients gave consent to the 
different research trials, which I regard as an oversight to ‘respect for autonomy’ as Gillon 
(1994, 184) describes it. A critique that I would assign to Case Two would be that the focus 
on patient autonomy (respect for self-rule) in terms of ‘applicability’ of each respective 
digitized method (e.g., SMS-texting, mHealth and IVR), was lacking, thus rendering PHI 
collected through the trials to be misplaced or sold to private companies - this being the 




7.3 Case Three: “In Their Shoes” by Takeda 
 
The third case is a project by Takeda, a patient-focused, innovation-driven global 
pharmaceutical company that builds on a distinguished 236-year history, aspiring to bring 
better health and a brighter future for people worldwide. 
 
Takeda is a pharmaceutical company based in Japan, Tokyo. The intended purpose of the 
business is to innovate the health market by serving the needs of patients and physicians 
worldwide. What the project lacks in peer-reviewed research supporting the data that has 
emerged from ‘In Their Shoes’, it makes up for in being an interesting and creative new way 
of looking at innovative strategies to accommodate patients suffering chronic disease, in this 
case Inflammatory Bowel Disease (IBD). The article Takeda posted on their official website 
depicts the following research trial process:  
 
“The program utilized a mobile application to guide participants through some of the 
common struggles patients face. An “IBD kit” of materials was used to participate in 
“challenges” prompted by the app. These challenges were designed to simulate 
several physical and emotional aspects of the disease. Through role-play scenarios 
and interactions with actors playing managers, nurses, and healthcare professionals, 
employees gained unparalleled insight into the impact IBD can have across all 
aspects of someone’s life, including professional and personal relationships.” 
(Takeda, 2017) 
 
In a recent project the pharmaceutical company has attempted to simulate what it’s like to be 
an IBD patient using an app. The innovative move was a decision made with the purpose of 
getting insight into the everyday life of an IBD patient, and employees of the company 
participated in the experiment by taking use of the app in everyday situations. The creative 
strategy is an attempt that is considered ‘outside the box’ as it does not only portray 
information about IBD but simulates the difficulties one can experience in a real-life situation 
given you are suffering from IBD. It was reported by the participants of the experiment as a 
fully encompassing and quite stressful experience, as they would have to respond accurately 
to messages, they would receive through the app they were given. Messages for when to go 
to the bathroom and such were common, and the participants would have to take 
 
 69 
precautionary measures that they otherwise would ignore in their day-to-day activities, such 
as always being close to a nearby bathroom in case they would get a message saying they 
have to go to the bathroom.  
 
For an IBD patients, symptoms like spontaneous bathroom breaks are not irregular. In fact, it 
is quite commonplace for IBD patients to research locales for bathroom opportunities prior to 
events or meetings, so that they can fluently find a nearby bathroom if a situation causing 
stomach upset might occur.  
7.3.1 Justice 
 
Gillon (1994, 185) argues that one can look at the ethical principle of justice in medical ethics 
and divide it into three categories.  
 
“In health care ethics I have found it useful to subdivide obligations of justice into 
three categories: fair distribution of scarce resources (distributive justice), respect for 
people's rights (rights-based justice) and respect for morally acceptable laws (legal 
justice).” (Gillon, 1994, 185) 
 
In discussing the degree in which justice has been thought of when conducting the 
experiment of ‘In Their Shoes’ we are going to apply the three categories as provided by 
Gillon (1994, 185) to see how each category relates to the conducting of the experiment, 
starting with how fairly the distribution of scarce resources (distributive justice) was in Case 
Three. 
 
The resources that were distributed in Case Three would be the equipment required for the 
trial to be conducted, namely the In Their Shoes app, the Takeda box with equipment and 
instructions and the telephone calls to assign role playing situations for each participant of the 
research experiment. In this research experiment the resources needed for conducting the 
experiment were first and foremost distributed to 22 employees at Takeda in Zurich, 
December 2015. This was the intention, according to project leader Audrey Liechti. One 
could say that the respect for distributive justice, then, was sufficient in terms of how all 
resources were given out to the participants of the study in the pilot period of the experiment. 
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Although critique in terms of distributive justice might be assigned to Takeda for conducting 
the In Their Shoes experiment with such a minor sample pool, being that the pilot of the 
experiment was rather minor with only 22 employees at Takeda in Zurich being included, one 
can argue that it is justified because of the unorthodox and innovative move of including 
actual employees in an experiment to simulate the symptoms of IBD, to then further develop 
a better consumer product that would help IBD patients using real-world experience. 
 
Once the pilot period of In Their Shoes was concluded, Takeda introduced the research 
project to several industries that assesses research on health-related issues, as evidenced by a 
Legemiddelindustrien (LMI) article assessing In Their Shoes and it’s benefits for patients 
suffering from IBD. To give some context, Legemiddelindustrien, which translates to 
“Pharmacy Industry”, is a company working to test and assess pharmaceutical products and 
research. Their website reads: 
 
“The pharmaceutical industry (LMI) is the industry association for the pharmaceutical 
industry in Norway. Norwegian and foreign pharmaceutical companies that develop, produce, 
sell or market pharmaceuticals in Norway may be members of the association. LMI will be 
the natural industry association for both large multinational companies and small Norwegian 
founding companies that operate in the pharmaceutical / life science area.” (LMI, 2018)  
 
In a short article published by LMI, LMI interviewed the communications director in charge 
for Takeda’s In Their Shoes project and did a short assessment of the research. LMI explains 
that the research project by Takeda has now expanded and several 100 employees at Takeda 
have been given the necessary resources and information to conduct the self-managing 
experiment in which they simulate what it’s like to suffer from IBD, which is a positive 
indication towards the ethical principle Gillon (1994, 184) refers to as distributive justice. In 
their article, LMI also explains that the research experiment has also been introduced to 
internal parties, namely individuals suffering from IBD, and not just Takeda companies, on 
an international scale. In light of this, we could argue that, in terms of ‘distribution justice’ as 
a category of justice, is sufficiently represented in Case Three.  
 
Next, we’re going to look at how respect for people’s rights (rights-based justice) is conveyed 
in the Takeda experiment. In looking at this subcategory of the ethical principle of justice, it 
is important to understand that all medical experiments must show a significant level of 
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respect for people’s rights (Gillon, 1994, 184). There is no evidence of unfair treatment 
conducted in the experiment, but the patients did suffer in their day-to-day life, being that 
they had to adjust their lifestyle in accordance with messages they would receive through 
telephone calls and through the app-system. Liechti explains that there were varied responses 
to the simulation experiment, but the overall opinion was that the experiment was “humbling 
and difficult”. Several inconveniences were experienced in the experiment, such as missing 
out on daily activities because the “patients” had to adhere to messages through the 
app/phone telling them to e.g., find the nearest bathroom, go to the bathroom, schedule 
physician calls and more, which are all commonalities of a typical IBD patient. This begs the 
question, to what degree is rights based on justice sufficiently taken into account in the 
conducting in Case Three? One could argue that even though the patients did suffer 
inconveniences as a result of participating in the experiment, it would be unfair to conclude 
that the participant’s rights were not looked after. In fact, suffering the inconveniences of the 
experiment was the entire goal of this medical experiment, which makes this medical 
experiment unorthodox in its approach, but the results according to the participants were 
positive as the information gathering potential through real-life simulation of IBD was 
immense. Due to there being no sign of not respecting the rights of the participants in Case 
Three (only the intended and minor day-to-day inconveniences), we can argue that In Their 
Shoes was sufficient in terms of adhering to the participants rights.  
 
Next, we’re going to discuss the last sub-category of justice, namely what Gillon (1994, 184) 
refers to as respect for morally acceptable laws (legal justice). The survey did not force the 
participants to break any legal laws, but there were certainly minor inconveniences in the 
day-to-day lives of the participants, which again was the intended purpose. The Takeda 
branch in Canada, represented by Edward Feijoo from Takeda Canada, had this to say about 
the medical experiment, “This experience really gave me a different sense of how disruptive 
the disease can be, and how strong you must be to still live a normal life”. However, Takeda 
did not report any of the participants having to break any laws as a result of participating the 
experiment, arguing that the respect for legal justice was sufficiently met in Case Three.  
7.3.2 Non-maleficence 
 
Case Three pinpoints the ethical dilemma of stress put on IBD patients to be excused in 
social situations which can, depending on the situation and person, feel as if it’s inappropriate 
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or in contrast to social norms. The participants in Takeda’s “In their Shoes” experiment was 
quick to realize that social pressure in situations where they were forced to break their daily 
routines and adapt to a simulated response from either a phone-call or the app, were difficult 
and at times caused an uncomfortable social scene. This experiment gave ordinary people the 
ability to feel the pressure of a situation an IBD patient experience frequently, opening for the 
discussion of social norms and how one should deal with situations were IBD patients 
experience social distress because they must leave social gatherings or meetings due to 
emergent issues related to their IBD.  
 
This brings us to the discussion of whether non-maleficence was practiced sufficiently and 
thought about in the conducting of this medical experiment. Case Three in terms of non-
maleficence is quite special, because the entire goal of the experiment was for the participants 
to experience the maleficent side-effects of being an IBD patient, however the intention for 
doing so and the purpose behind In Their Shoes was to learn more about IBD. The answer 
would then have to be that there indeed was maleficent repercussions, e.g., participants 
having to sacrifices activities in their day-to-day lives to adhere to the simulated messages in 
the simulation program that the participants had to partake in, but because the participants 
knew this going into the medical experiment, consent was given, and because the intentions 
behind the medical experiment was to better accommodate patients suffering from IBD, the 
conclusion could be argued to weigh more towards that non-maleficence as an ethical 
principle was sufficiently represented. To sum up this, we could say that there indeed was 
minor maleficence as the participants experienced inconveniences, but the greater result was 
beneficence and the overall net-benefit prevails in this medical experiment. 
7.3.3 Beneficence 
 
The goal of beneficence is to produce net-benefit with no harm done to the participants of a 
medical experiment, and it is closely in symbiosis with non-maleficence (to not hurt the 
patients undergoing the medical experiments). In case three, one could argue that the 
beneficence was that Takeda was spreading awareness and information about a rather 
disclosed and taboo subject, opening it up to be assessed, discussed and experienced by 
medical workers (employees at Takeda) to better understand why IBD patients feel the way 
they feel. The reach of this program is evident by Takeda’s article, pinpointing just how 




“Beyond the initially focused internal audience of Takeda, the team has continued to 
expand the program across broader audiences (HCPs, journalists and institutions) in 
the Europe and Canada region. In each country where the program has been 
initiated, patient associations were involved.” (Takeda, 2017) 
 
As evidence to this statement, the article that LMI published on In Their Shoes talks about 
how In Their Shoes had been featured on the popular Norwegian news site VGTV, which 
features a politician by the name of Bård Hoksrud talking about the importance of 
understanding the implications of IBD and opening up the conversation to the public, 
removing the stigma around some of the symptoms IBD patients may experience.  
 
Another point to beneficence was made when an employee in Takeda came forward, 
according to Takeda’s article, and talked about her struggle with the symptoms of IBD 
combined with long-haul flying and traveling in general. This prompted another initiative that 
Takeda intends to work more on called #FlyWithIBD, calling on airlines to serve IBD-
friendly food.  
7.3.4 Autonomy 
 
We have learned previously that autonomy is the respect for self-rule and letting patients in 
on information when medical trials are conducted. In the case of Case Three, it is evident by 
the Takeda article that autonomy is the driving factor of the medical experiment. We can 
argue this because the entire medical procedure is monitored and controlled by the 
participants themselves, and the information is relayed back to the participants, being that the 
participants are employees working on finding better solutions to accommodate patients 
suffering from IBD. Thus, in the case of autonomy and the respect for self-rule in Case 
Three, it’s a self-fulfilling prophecy. The experiment is conducted by participants and the 
participants are also the ones who will take use of the information that is acquired from the 
experiment. The respect for self-rule is therefore undoubtedly sufficiently represented in Case 




8 Addressing the Characteristics and Heterogeneities of 
the Three Cases  
 
In this next chapter the intent will be to describe the differences between the cases, namely 
what makes them strong or weak in terms of their applicability in the health industry, how 
they differ in terms of sufficiently representing the four ethical principles that Gillon (1994) 
outline for medical workers as ethical guidelines to uphold and also we’re going to look at 
how the cases differ in terms of their approach to retrieving information or solving a 
particular medical problem, through the use of digitized accommodation methods.  
 
The choice to include three digitized cases of accommodating patients suffering from chronic 
disease that were all different in their approaches, but at the same time all intended to achieve 
the same results in terms of retrieving valuable information about a chronic condition, was 
made to showcase the disparities in approaches that has been made in the field of digitizing 
accommodation approaches for chronic health patients, and consequently also show how the 
ethical implications also are different in each respective case, depending on its approach.  
 
Starting off with Case One, we immediately identify that the case is focused towards one 
target group, namely war veterans in the U.S suffering from low back pain. This makes Case 
One stand out in contrast to Case Two, as Case Two is a review of literature on digitized 
accommodation measures to accommodate patients suffering chronic diseases and a 
displaying of the findings and applicability of said accommodation methods, thus focusing on 
quantity (in terms of information inquiry) rather than a single target group (war veterans). 
Case One is also different from Case Three, being that Case Three has an unorthodox 
approach to retrieving relevant information about IBD, namely a digitized simulation of a 
disease (IBD) rather than approaching the chronic disease through a clinical trial intending to 
treat the patient.  
 
In Case One, we find that the case is ethically well represented in terms of it being focused on 
a smaller target group (war veterans), reflected by the fact that Piette et al (2016) describe the 
methodological approach to gain consent from patients in high detail. The represented ethical 
principle in this case would be one of the sub-categories under justice, as defined by Gillon 
(1994), namely respecting a patient’s right to refuse treatment and forfeit their patient status 
in medical experiments and respecting the social and moral laws of conducting a medical 
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experiment. The statement below showcases how carefully Case One approaches the issue of 
obtaining patient-consent: 
 
“After obtaining agreement from patients’ primary care providers, a letter will be sent to 
veterans informing them about the study and inviting participation. Veterans who do not opt-
out by postage-paid response card will be called by research staff to explain the study, 
conduct screening, and solicit their involvement. If the veteran is willing, s/he will be sent the 
consent form by mail along with a postage-paid return envelope.” (Piette et. al., 2016) 
 
There was also a list of requirements that patients needed to meet in order to participate in the 
medical experiment that Case One showcases, which especially highlights the ethical 
principle of beneficence in its symbiotic relationship with non-maleficence, as described by 
Gillon (1994). It is identifiable that the overall goal is to produce net-benefit in terms of 
information inquiry and helping war veterans treat their chronic low back pain, but at the 
same time Case One also has respect for the patient by stating numerous health requirements 
that each respective patient must meet in order to participate in the medical experiment. In 
contrast, this is very much lacking in both Case Two and Case Three, as they do not set forth 
specific medical requirements for each patient participating in the medical experiment.  
 
It can be argued that Case Two is unique in the way it has a broader reach in terms of its wide 
methodological approach to information inquiry, including not just one digitized method of 
accommodating patients suffering from CVD, but several accommodation methods (e.g., 
IVR, Social Media, SMS-Texting and RL). It also targets not just one geographical area, in 
contrast to Case One which mainly focus on the U.S, but targets several geographical areas 
and the geographical, economical and ethical challenges of implementing the accommodation 
methods that Case Two reviews in these geographical areas. It can be argued that this is what 
makes Case Two such a prominent candidate in representing the sub-category of justice as 
described by (Gillon, 1994), namely distributive justice, in contrast to Case One which focus 
is primarily on U.S war veterans suffering from low back pain. Case Two also differs from 
Case Three in terms of distributive justice as Case Three was more oriented around the 
employees at Takeda, rather than focusing on LMICs and HICs and a wide range of medical 
approaches, which is the purpose of Case Two. That said, it should be mentioned that Case 
Three did expand gradually to include more patients suffering from IBD, but this process was 
gradual and Case Three was not intended to be a large-scale medical experiment, judging by 
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the Takeda article. Judging by this information, we find that the ethical principle of justice is 
more sufficiently represented in Case Three than in Case One and Two, as Case Three’s main 
purpose is to display the results and statistics in digitized medical experiments. Because Case 
Three is more large-scale and data-driven (results oriented), it focuses heavily on one of the 
ethical principles that Gillon (1994) mentions as one of the three categories of justice, namely 
a focus on justly distributing scarce resources/information that patients of chronic conditions 
need in a given medical experiment through a focus on LMICs as well as HICs. However, in 
studying Case Two we find that it’s focus is quite derivative of the remaining two sub-
categories of justice, namely rights-based justice and legal justice. Because of the quantity of 
cases reviewed in Case Two it can be argued that people’s rights (rights-based justice) was 
not sufficiently represented in the method of approach in each given medical experiment, or 
at least this was not part of the focus in reviewing the literature surrounding digitized medical 
approaches to patients suffering from CVD in HIC and LMIC (Case Two). One could also 
play devil's advocate in favor of Case Two, pinpointing that it's important to understand that 
Case Two was indeed based on quantitative research, thus producing quantity in terms of a 
wider disparity in the results, rather than a focus on quality and thus a more patient-
consensual approach to accommodate patients suffering chronic disease.  
 
Beneficence in terms of producing a net-benefit is also something that one could argue Case 
Two has sufficiently represented. Gillon (1994, 184) describes this ethical principle as 
‘producing net-benefit’ which is exactly the main goal of Case Two; displaying a vast array 
of different results in medical approaches to accommodate patients suffering from CVD. The 
net-benefit in Case Two would be the evaluation of different medical approaches and the 
information inquiry that comes from this, as this evaluated information could be used to help 
health investors decide upon which technologies they should invest in and produce more of 
when it comes to better accommodate patients suffering CVD in LMICs and HICs. The 
quantity over quality approach is therefore both negative in terms of respecting individual 
patients’ rights and social/moral laws (rights justice, legal justice and nonmaleficence) and 
positive in terms of net-benefit and its global reach (beneficence and distributive justice). 
 
In assessing Case Three we find a vastly different approach than both Case One and Two, 
being that its intention is to simulate a disease (IBD), which is the very opposite approach of 
Case One and also the approach in the literature reviewed in Case Two that both focus on 
digitized accommodation methods of treating a disease. This creative approach might be 
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lacking in terms of non-maleficence, being that the participants of the research project had to 
actually simulate a disease which has detrimental effects on health, causing the participants to 
suffer in their day-to-day planning of activities, but make up for it in how effective the 
medical experiment was in terms of autonomy. The information inquiry in Case Three did not 
follow the usual patient-producer-physician information chain, but rather did a full circle in 
terms of the intended recipient of the information coming out of the experiment was also the 
patient, namely the coworkers at Takeda who participated in the experiment during the trial 
period. This is a fully autonomous system, as the notion of ‘self-rule’ is completely 
encompassed in the conducting of the medical experiment. The reason we mention this is 
because, in contrast to Case One and Two, we cannot identify this level of ‘self-rule’, making 





In this chapter I will attempt to conclude the findings made in the thesis and summarize the 
most defining arguments that has been presented in this thesis. Lastly and to conclude this 
thesis, this section will include an educated prediction as to what will happen in the field of 
digitization of health-related approaches to accommodate chronic patients, and present 
further research in the field that I would hope to witness in the years to come.  
9.1 Findings and summary 
 
To conclude the findings that we have uncovered in this thesis, it is important to note the 
required relationship between ethics and technology, namely digital technologies in the 
health sector, and that this relationship always continues to evolve with the four ethical 
principles in mind. This must be a priority for ethics boards all around the globe in 
determining whether one should invest in digitized health accommodation systems for 
patients suffering chronic diseases, and I hope the information that I conveyed in this thesis 
will help guide that decision.  
 
It can be argued that in discussing the collaboration of different fields in order to ensure that 
AI stays ethical we have found that it is required that the underlying factors of ethics are 
understood and considered when incorporating ethical values in health-related products and 
procedures. The complexity of writing on anything regarding ethics is quite difficult when 
it’s isolated to ethics, but when you incorporate medicine, the layers and complexity become 
far more immense, again underlining the inherent need for seemingly different fields of 
science to communicate and work in a symbiotic relationship. For instance, one cannot 
consider the applicability of a digitized medical experiment without considering, consulting 
and inquiring information about the history of medical ethics. 
 
We have found that there are ethical implications in digital technologies when they relate to 
the health sector, such as the generation gap, implications of storing personal data, the 
implication of adopting a deterministic view on technology and the importance of face-to-
face conversation and lack thereof in digital services with the intent to accommodate patients 
suffering chronic disease. In addressing Gillon (1994) we have found that there are four 
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ethical principles that determine whether a medical experiment can be considered morally 
sufficient. These principles have been the result of an ongoing evolution of ethical discourse 
in the field of physician-patient relationship, as documented by Will (2016) in his article on 
the evolution from a beneficence-oriented health model to a more autonomous model. We 
have also found that there are disparities in the cases, each case having a different approach 
in terms of one being a medical experiment, one being a review of peer-reviewed literature 
and the last being a simulated medical experiment. Because of these different methodological 
approaches as to how one can accommodate patients suffering chronic diseases in a digitized 
manner, we find that each respective case is represented differently on the spectrum of 
medical ethics. What one case lacks, another makes up for in terms of sufficiently 
representing an ethical value, and vice versa. This leaves us with the overall interpretation 
that each case of accommodation patients suffering chronic disease has valuable information 
extracted from it, and the disparity in how the issue of accommodating patients suffering 
chronic disease was approached in each medical experiment, played a part on what kind of 
information the medical experiment produced, and also played a part in how well the medical 
experiment represented each respective ethical principle.  
9.2 Further Research in the Field 
 
In writing this thesis, I hope that the research continues to evolve in a symbiotic relationship 
with ethical guidelines, so that medical experiments intended on treating patients with 
chronic diseases don’t have a perverse effect. Physicians and companies working in the 
health industry must not let their curiosity or financial needs given priority over the ethical 
principles in support of patients’ rights, legal rights, distributive justice, nonmaleficence, 
beneficence and autonomy, in medical experiments, trials and products. Understanding the 
digital is crucial, not only in the present moment, but also for the future. Developing a strong 
relation and understanding of what it means to be in the Fourth Industrial Revolution with 
digital influence in almost every activity will hopefully highlight the digital implications of 
this digital era in a more preemptive manner, so we can deal with the ethical implications 
before they actually take place and cause distress to our wellbeing and way of life.  
 
More specifically, it is my hope that Case One will uncover more revealing information about 
the applicability of the digitized approaches Case One introduces us to, to accommodate war 
veterans in the U.S suffering from low back pain. The results according to Piette et al (2016) 
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will be readily available in the Winter of 2019. Perhaps this will reveal more ethical 
implications in terms of the generation gap and how U.S war veterans of the elderly 
generation might’ve had trouble relating to a digitized accommodation method.  
 
Another interesting development one could hope for would be to see if ‘In Their Shoes’ by 
Takeda is going to produce or inspire more academic articles or journal entries on the ethical 
issues surrounding IBD, as the Takeda article by itself did lack in credible and peer-reviewed 
information, which it made up for in its creative approach to accommodating patients 
suffering from IBD. Takeda did point out that other movements, such as #FlyWithIBD, were 
inspired by the digitized accommodation measure. This is hopefully a step in the direction of 
more academic funding and focus on IBD and the different digitized methods one can 
approach the treatment of this highly prevalent disease.  
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10   List of abbreviations 
 
AI-CBT: Artificially Intelligent Cognitive Behavioral Therapy 
CBT: Cognitive Behavioral Therapy 
HIPAA: The Health Insurance Portability and Accountability Act 
HIC: High Income Country 
IVR: Interactive Voice Response 
LMIC: Low to Middle Income Countries 
mHealth: Mobile Health 
PHI: Patient Health Information 
RL: Reinforcement Learning 
SMS: Short Message Service  
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11   List of frequent terms used 
 
Reinforcement Learning: description of an adaptive algorithm with simulations.  
Cognitive Behavioral Therapy: psychotherapy with the intent of treating a patient through 
conversational tactics and guidance. 
Interactive Voice Response: telephone call between a physician and a patient with the intent 
to council a patient through guidance and therapeutic stimuli. 
Mobile Health: a tool for communication regarding health between a patient and physician, 
oftentimes in an autonomous system to provide or give feedback regarding a health issue. 
SMS: a short message service from a mobile phone that provides text in a mobile format, 
often in the context of sending information from A to B.  
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